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InTroduCTIon
Despite the remarkable development in our understanding of cardiovascular diseases, 
they are still responsible for about one-third of all deaths in Western societies1. The major 
contributor to mortality is coronary artery disease leading to acute myocardial infarction, 
causing 12% of all global deaths1. In the last decades coronary artery disease has reached 
endemic proportions, putting an enormous strain on health care economics, and with the 
aging population this is expected to increase in the future.
As a result, the patient population observed in cardiology practice is changing. Not only 
the number of patients with suspected and known coronary artery disease has increased, 
but also the population of chronic heart failure patients has grown and will continue to 
increase, due to the aging population and the improved survival after acute myocardial 
infarction2. In addition, due to the developments in cardiothoracic surgery, there is an 
increasing number of patients with congenital heart disease reaching adulthood and 
entering the adult cardiology outpatient clinic3. Those patients are not only at risk for late 
cardiac complication, but also for developing coronary artery disease as they are exposed 
to the same risk factors for cardiovascular disease as every other person living in a Western 
society.
For appropriate management and treatment of this growing and diverse patient popula-
tion encountered in cardiology practice, the assessment of the proper diagnosis and the 
evaluation of the cardiac condition of the patient remains the first important step. There-
fore, enormous efforts have been made over the past decades to improve invasive and 
non-invasive cardiac imaging4. As a result, a great variety of techniques is now available 
in daily clinical routine. According to the information that is provided by the different 
imaging techniques, they can be divided into two major groups: anatomical imaging and 
functional imaging. In anatomical imaging the focus is on visualizing the coronary artery 
tree, atherosclerotic plaques and myocardial structure. Functional imaging focusses on 
assessment of myocardial perfusion, myocardial contractile function and myocardial sym-
pathetic innervation. At present, cardiac imaging not only has contributed to the applied 
diagnostic algorithms, it also had its impact on therapeutic strategies and prognostication 
of patients with cardiovascular disease.
Among the available anatomical imaging techniques, computed tomography coronary 
angiography (CTCA) has emerged as one of the most potent cardiac imaging technique 
for non-invasive evaluation of the presence of coronary arterial atherosclerosis. Because 
of high negative predictive value, CTCA has an excellent ability of ruling out significant 
coronary artery disease5. Moreover, in the presence of significant coronary artery disease, 
CTCA provides information about the type of atherosclerotic plaque that is causing the 
luminal narrowing, such as calcified plaques, mixed or soft tissue plaques. This information 
is valuable for further therapeutic decision making, as the type of atherosclerotic plaque 
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provides important prognostic information6. Importantly, other information that is always 
included and is easily assessed on CTCA is information about cardiac anatomy including 
coronary arterial dominance. Coronary arterial dominance is defined by the coronary artery 
that supplies the posterior descending artery (PDA) and posterolateral branches. Up till 
present, the value of this anatomical information may be underestimated. Coronary arterial 
dominance influences the relative contribution of the different coronary arteries to the 
total left ventricular blood flow7. Therefore, a significant coronary artery obstruction may 
jeopardize a large amount of myocardium in one patient, and less in the other patient, 
depending on the coronary anatomy. Subsequently, coronary arterial dominance may have 
prognostic value in patients with suspected or known coronary artery disease (PART I).
Another advantage of CTCA is that it provides the possibility to reconstruct the coronary 
arterial tree in three-dimensional view. Compared to conventional invasive coronary angi-
ography, the three-dimensional view of CTCA makes it easier to determine the origin of 
the coronary arteries and the coronary course in relation to the great arteries. This can be 
of a particular value in patients with a higher risk of having anomalous coronary arteries, 
such as patients with congenital heart disease (ParT I).
As a result of better primary prevention and early detection of the presence of significant 
coronary artery disease, the occurrence of an acute myocardial infarction can be prevented 
in many cases. Moreover, in case of an acute ST-elevation myocardial infarction (STEMI), 
survival has significantly improved due to the aggressive therapy with primary percutane-
ous coronary intervention8. On the other hand, as previously mentioned, this improved 
survival of STEMI patients in combination with an aging population, resulted in a growing 
number of patients with chronic ischemic heart disease2. Therefore, the role of secondary 
prevention in limiting the number of reinfarction and heart failure in post-STEMI patients 
has increased. Despite the therapeutic innovations over de last decades, a considerable 
number of patients develops heart failure post-STEMI. Unfortunately, the mortality rates 
of patients with heart failure remain high with an estimated 5-year mortality rate of 59 % 
in men and 45 % in women9. Therefore, interest has grown in the development of tests 
capable of providing insight into future risk for heart failure progression and arrhythmic 
sudden cardiac death. One potential area for such testing is the sympathetic innervation 
of the heart using 123-iodine metaiodobenzylguanide (123I-MIBG) scintigraphy. The recent 
developments in sympathetic nerve imaging with 123I-MIBG imaging may be useful for the 
risk stratification of patients with chronic heart failure (ParT II).
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ImPorTanCE of Coronary arTErIal domInanCE In 
PaTIEnTs wITh susPECTEd and known Coronary arTEry 
dIsEasE (ParT I)
Variations in coronary circulation are common, particularly with regard to the supply of 
the posterior wall of the left ventricle. In approximately 88% of people in the general 
population the posterior descending artery (PDA) originates from the right coronary artery 
(RCA), defined as a right dominant coronary artery system10,11. A left dominant coronary 
artery system, with a PDA originating from the left circumflex artery (LCx), is far less 
prevalent with reported proportions between 7 and 10%. When the PDA originates from 
the RCA in combination with large posterolateral branches from the LCx artery, reaching 
near the interventricular groove, there is a balanced coronary artery system, as present in 
approximately 4% of people10.
In patients with a left dominant coronary artery system (Figure 1), around 60% of the 
left ventricular myocardium is supplied by the dominant LCx artery, making this the most 
important coronary vessel of the coronary artery tree in these patients. Not only the LCx 
artery is more important in patients with a left dominant coronary system, also the left 
anterior descending artery (LAD) is longer and wrapped around the apex of the heart in 
87% of these patients12. Moreover, patients with a left dominant coronary system seem 
to have less ability to form adequate collateral circulation in case of significant coronary 
obstruction13. This inferiorly balanced coronary circulation may have negative influence on 





figure 1. Conventional coronary angiogram of a patients with a left dominant coronary artery system. 
In this patient the RCA is small, only supplying the right ventricle. The entire lateral and posterior wall of 
the left ventricle is supplied by the dominant LCx artery.
*This patient had a subtotal occlusion of the proximal LAD artery, which was stented during primary PCI.
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At present, little is known about the prognostic relevance of this anatomical variation. 
A study screening 1620 postmortem angiograms showed that the prevalence of a left 
dominant coronary artery system decreased with age, suggesting a higher death rate 
among patients with a left dominant coronary artery system14. An explanation could be the 
larger amount of myocardium that is at risk in these patients, resulting in more extensive 
myocardial infarction in case of a left coronary artery occlusion.
Data describing the prognostic value of coronary arterial dominance in patients with 
coronary artery disease are scarce. A previous study by Goldberg et al. in a large cohort 
of patients undergoing cardiac catheterization due to acute coronary syndrome, showed 
that the presence of a left dominant coronary artery system was a predictor of death15. In 
addition, a study by Ilia et al. showed that an acute occlusion of a proximal dominant LCx 
artery resulted in a higher proportion of patients presenting with cardiogenic shock and 
higher in-hospital mortality rate when compared with patients with a proximal LAD artery 
occlusion16.
Better awareness of the prognostic relevance of coronary arterial dominance may im-
prove risk estimation of future adverse events in patients with coronary artery disease 
assessed on CTCA and in patients after STEMI.
Abnormal coronary artery anatomy in adults with congenital heart disease 
According to literature, coronary anomalies affect approximately 1% of the general 
population17. However, due to the interplay between cardiac malformation and coronary 
figure 2. Schematic drawing of the arterial switch operation performed with the Lecompte manoeuvre 
for the correction of the transposition of the great arteries. Both big arteries are transected and the 
pulmonary root is completely clear for visualization of the coronary arteries arising from the pulmonary 
artery. The coronary arteries are then transferred to the aorta, using a ‘button-technique’. This is the 
most challenging step during the operation. Reprinted from Thesis of J.M. Quaegebeur, with permission.
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morphogenesis, the incidence of coronary anomalies is much higher in patients with 
congenital heart disease. Different incidences for the presence of coronary artery abnor-
malities in patients with congenital heart disease are reported, ranging from 9-12% 18. 
In these patients, knowledge about the coronary origins and their course is essential for 
optimal surgical repair shortly after birth, particularly when the coronary arteries need 
to be replaced as part of the correcting surgery. The presence of coronary anomalies in 
these patients can cause an increased risk of ischemic damage during surgical correction19. 
Moreover, coronary complications later in life are observed more often in patients with a 
variant coronary artery pattern20.
In patients with transposition of the great arteries an arterial switch operation is the pre-
ferred surgical approach. The principle step in the arterial switch operation is the transfer 
of the coronary arteries into the neo-aorta (Figure 2). The arterial switch operation was 
performed first in 1977 and more routinely in the years thereafter. Subsequently, most 
patients who underwent this type of surgery are now reaching adulthood. Late cardiac 
complications that are reported in patients with transposition of the great arteries cor-
rected by arterial switch operation include dilation of the neo-aortic root and coronary 
obstructions21. Particularly patients with variant coronary artery anatomy seem to have 
a higher risk of developing significant coronary lesions during follow-up after the arte-
rial switch operation. Importantly, due to perioperative sympathetic denervation, these 
patients often remain asymptomatic22. Therefore, the evaluation of the patency of the 
coronary arteries is of major importance in these patients. Because of its non-invasive 
nature and the advantage of three-dimensional imaging, enabling precise determination 
figure 3. Three-dimensional and axial image of the coronary artery tree of a patient with a variant coro-
nary artery pattern. In this patient the LCx is arising from the RCA. The LAD forms the single left coronary 
artery. Using different post-processing procedures in the evaluation of the images, the coronary course 
can be appreciated nicely in relation to the great arteries.
16
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of the origin and course of the coronary arteries in relation to the great arteries, CTCA is 
the preferred technique for the evaluation of the coronary arteries in these young adults 
(see example case in Figure 3).
With the increasing number of patients with congenital heart disease entering the adult 
cardiology outpatient clinic, it is of major importance that cardiologists become familiar 
with the spectrum of abnormal coronary findings that may be encountered in these pa-
tients.
usE of CardIaC 123-IodInE mETa-IodobEnzylGuanIdE 
ImaGInG In PaTIEnTs wITh ChronIC hEarT faIlurE (ParT II)
The heart is innervated by the autonomic nervous system, consisting of the sympathetic and 
parasympathetic system by which it controls the cardiac performance, such as contractility, 
conduction and heart rate. The sympathetic nervous system is dominant in the ventricles 
with norepinephrine as most important neurotransmitter. In heart failure patients, there is 
an increased myocardial sympathetic activity as the failing heart tries to compensate for 
the reduced cardiac output23. At the cellular level, the increased sympathetic activity causes 
increased neuronal release of norepinephrine. This increase in norepinephrine eventually 
leads to posttranscriptional downregulation of the cardiac norepinephrine transporters 
causing a significant reduction of presynaptic norepinephrine uptake24.
Meta-iodobenzylguanidine (MIBG) is a 123I-labelled norepinephrine analogue allowing 
visualization of the myocardial sympathetic neuronal uptake. The amount of myocardial 
123I-MIBG uptake is expressed as the heart-to-mediastinum (H/M) ratio, with the very low 
amount of 123I-MIBG uptake in the mediastinum as reference (Figure 4).
A large number of investigators have demonstrated decreased myocardial 123I-MIBG 
uptake in patients with heart failure. This decreased uptake was shown to be related with 
future adverse events, while patients with the lowest uptake tend to have the poorest 
prognosis (Figure 5)25.
Despite the demonstrated prognostic value cardiac 123I-MIBG imaging in chronic heart 
failure patients, clinical use of this procedure remains limited26. Potential reasons for the 
limited clinical impact of cardiac 123I-MIBG imaging has been the variability in the technical 
aspects of the procedure. Most of the publications include the H/M ratio as the measure of 
myocardial uptake, however the methods used to obtain this parameter showed consider-
able variation. Subsequently, there is a need for standardization of this imaging technique 
to improve its usefulness as a prognostic tool in heart failure patients.




figure 4. The mediastinal region of interest (ROI) and the manually drawn cardiac ROI on a planar 123I-
MIBG image. In patients with severe heart failure the cardiac uptake of 123I-MIBG can be very low, mak-
ing it harder to define the accurate location of the cardiac ROI.
All‐cause mortality, arrhythmic event and heart failure progression
figure 5. Kaplan-Meier curve showing the cumulative event rate of the composite end-point all-cause 
mortality, arrhythmic event and heart failure progression in patients with high and low Heart-to-Medias-
tinum ratio (H/M). Patients with a low H/M ratio had significantly more adverse events during 2 years of 
follow-up. Reprinted with permission from Jacobsen et al.25 
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objECTIVE and ouTlInE of ThE ThEsIs
In current cardiology practice different cardiac imaging techniques are used to detect 
the presence of coronary artery disease, evaluate the cardiac performance in post-STEMI 
patients and guide therapeutic decision making in patients with heart failure. Yet, due to 
the vast array of choices, it is challenging for the cardiologists to take full advantage of the 
different cardiac imaging modalities. Therefore, the aim of this thesis was to use all infor-
mation provided by the different imaging techniques and improve the clinical usefulness 
of cardiac imaging in different patient categories encountered in daily cardiology practice, 
with the purpose of improving risk estimation in patients with suspected coronary artery 
disease, patients who suffered from STEMI and heart failure patients.
In Part I of this thesis the prognostic importance of coronary artery anatomy in patients 
with suspected and known coronary artery disease is investigated. More specifically, 
chapter 2 shows that the evaluation of coronary arterial dominance on CTCA, next to the 
assessment of the presence, severity and extent of coronary artery disease, can enhance 
risk stratification of patients with suspected coronary artery disease. Chapter 3 describes 
the influence of coronary arterial dominance on short-and long-term outcome in post-
STEMI patients, recognizing the presence of a left dominant system as one of the risk 
factors for future adverse events in patients after STEMI. In chapter 4 the relation between 
coronary arterial dominance and echocardiographically assessed left ventricular ejection 
fraction in post-STEMI patients is evaluated. Chapter 5 shows the usefulness of CTCA for 
the evaluation of coronary anatomy in adult patients late after arterial switch operation 
for the correction of the transposition of the great arteries. Moreover, it describes the 
relation between the observed variations in coronary anatomy, the presence of potential 
harmful abnormal coronary findings and the development of neo-aortic root dilation in 
these patients.
In part II of this thesis the clinical usefulness of cardiac 123I-MIBG imaging for the evalu-
ation of sympathetic innervation of the myocardium in patients with chronic heart failure 
is investigated. In chapter 6 the reproducibility of the clinically important parameters on 
planar 123I-MIBG myocardial scintigraphy is assessed, with the purpose of improving stan-
dardization of the method and therewith increase its usefulness in the clinical management 
and prognostication of patients with chronic heart failure.
General Introduction and Outline of the Thesis
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Limited information is available regarding the relationship between coronary vessel 
dominance and prognosis. Therefore, the purpose of this study was to determine the 
prognostic value of coronary vessel dominance in relation to significant coronary artery 
disease (CAD) in patients referred for computed tomography coronary angiography (CTA).
Methods and Results: 
The study population consisted of 1425 patients (869 men, 57±12 years) referred for CTA. 
To evaluate the impact of vessel dominance and significant CAD on CTA on outcome, pa-
tients were followed during a median period of 24 months for the occurrence of non-fatal 
myocardial infarction and all-cause mortality. The presence of a left dominant system was 
identified as a significant predictor for non-fatal myocardial infarction and all-cause mortal-
ity (HR 3.20; 95%CI 1.67-6.13, p<0.001) and had incremental value over baseline risk fac-
tors and severity of CAD on CTA. In addition, in the subgroup of patients with significant 
CAD on CTA, patients with left dominant system had worse outcome compared to patients 
with a right dominant system (cumulative event rates: 9.5% and 35% at 3-year follow-up 
for right and left dominant coronary artery system, respectively, log-rank p<0.001).
Conclusions: 
The presence of a left dominant system was identified as an independent predictor of non-
fatal myocardial infarction and all-cause mortality, especially in patients with significant 
CAD on CTA. Therefore, the assessment of coronary vessel dominance on CTA may further 
enhance risk stratification beyond the assessment of significant CAD on CTA.
Prognostic value of coronary vessel dominance on CT coronary angiography
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InTroduCTIon
Non-invasive computed tomography coronary angiography (CTA) is increasingly used in 
clinical practice for visualization of the coronary arteries in patients with suspected or 
known coronary artery disease (CAD)1-3. Multiple studies demonstrated high diagnostic 
accuracy of CTA in detection of CAD. In addition to the good diagnostic performance, 
CTA also provides important prognostic information4,5. Several studies have shown that 
patients with significant CAD detected on CTA have worse overall outcome compared to 
patients without significant CAD6,7. However, CTA not only provides information about 
the presence and degree of coronary stenosis, it also allows the evaluation of cardiac 
anatomy including coronary vessel dominance. As a result, coronary vessel dominance is 
routinely determined on CTA. In the general population, right dominant coronary artery 
system is most prevalent, approximately 87% to 89%, while left dominant coronary artery 
system has a prevalence of 7% to 8% and balanced coronary artery system is present 
in approximately 4% of the population8-10. Although coronary vesssel dominance is eas-
ily assessed on CTA, limited information is available considering the prognostic value of 
coronary vessel dominance in patients referred for CTA. Moreover, the relation between 
coronary vessel dominance and the prognostic importance of a significant stenosis remains 
unclear. Therefore, the purpose of this study was to evaluate the prognostic relevance of 
coronary vessel dominance in the presence and absence of CAD determined on CTA.
mEThods
Patients and study protocol 
The study population consisted of consecutive patients who were clinically referred for CTA 
because of typical chest pain or atypical chest pain in combination with an elevated risk 
profile for cardiovascular disease. Patients were enrolled at the Leiden University Medical 
Center in the Netherlands and at the University Hospital Zurich in Switzerland. Exclusion 
criteria were: 1) previous coronary artery bypass graft surgery (CABG); 2) (supra)ventricular 
arrhythmias; 3) renal insufficiency (defined as a glomerular filtration rate <30 ml/min); 4) 
known allergy to iodinated contrast agent; 5) severe claustrophobia and 6) pregnancy. 
Patient data were entered consecutively into the departmental patient information sys-
tems and retrospectively analysed. Patients with uninterpretable CTA examination were 





Patients were scanned using a 64-row CT scanner (Aquillion64, Toshiba Medical Systems, 
Otawara, Japan; General Electrics LightSpeed VCT, Milwaukee, WI, USA) or with a 320-
row CT scanner (Aquilion ONE, Toshiba Medical Systems). Before examination patient’s 
heart rate and blood pressure were monitored. In absence of contra-indications patients 
with a heart rate exceeding 65 beats/min received 50 or 100 mg oral metoprolol, or 5 
to 10 mg metoprolol, intravenously. Scan acquisition parameters have been previously 
described5,11,12. A reconstruction dataset with the least motion artifacts was evaluated typi-
cally acquired during a mid-diastolic phase.
CTA image analysis
CTA reconstructions were transferred to dedicated workstations (Vitrea2, Vital Images, USA 
and Advantage, GE Healthcare, USA). CTA image analysis was performed by 2 observers in 
consensus, experienced in the evaluation of CTA. Coronary anatomy and coronary vessel 
dominance was assessed in a standardized manner by dividing the coronary artery tree into 
17 segments according to the guidelines of the American Heart Association13. A coronary 
artery system was classified as right dominant when the posterior descending artery (PDA) 
originated from the right coronary artery (RCA), whereas a coronary artery system was 
considered left dominant if the PDA originating from the left circumflex artery (LCX). A 
coronary artery system was classified as balanced, when the PDA originated from the RCA 
in combination with a large postero-lateral branch originating from the LCX reaching near 
the posterior interventricular groove. Subsequently, the presence of CAD was assessed by 
scrolling through axial images, simultaneous with visual assessment of curved multiplanar 
reconstructions in at least 2 orthogonal planes. All 17 coronary segments were scored 
as 1) normal CTA or minor wall irregularities <30%, 2) non-obstructive CAD (defined as 
30-50% luminal narrowing) or 3) significant CAD (defined as ≥50% luminal narrowing), as 
previously described5. In case of stented coronary segments, the presence of in-stent reste-
nosis was analyzed as described before14,15. CTA results on a per patient basis were scored 
according to the 5 step score assessing both degree of stenosis and number of vessels 
affected, as previously described by Chow et al.16. The 5 categories were normal coronaries 
or minimal wall irregularities <30%, non-obstructive CAD and 1-, 2-, and 3-vessel disease.
Patient follow-up
Patients were entered prospectively into the departmental patient information system 
over a period of three years time. Follow-up information was obtained for all patients six 
months post-index CTA of the last patient entering the study. Based on the difference in 
inclusion date, follow-up time varied among patients with a minimal follow-up time of 6 
months and a maximal follow-up of 3.5 years. Patient follow-up data were gathered by 3 
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observers blinded to the baseline CTA results using clinical visits or standardized telephone 
interviews.
Outcome measures
The primary endpoint was the composite of non-fatal myocardial infarction (MI) and 
all-cause mortality. Non-fatal MI was defined based on the criteria of typical chest pain, 
elevated cardiac enzyme levels, and typical changes on the ECG17. A secondary outcome 
was the occurrence of cardiac adverse events, defined as the composite of non-fatal MI and 
cardiac death. To obtain the cause of death, the electronic health records of the cardiology 
department were first consulted. If the cause of death could not be retrieved from these 
health records, general practitioners were contacted. Cases that remained unidentified 
were classified as unknown.
Statistical Analysis
Continuous variables were expressed as means and standard deviations (SD) and categorical 
baseline data were expressed in numbers and percentages. Kaplan Meier analyses stratified 
for coronary vessel dominance were performed to estimate the cumulative incidences of 
the primary and secondary endpoint in the total population, in patients without significant 
CAD on CTA and in patients with significant CAD on CTA. Annual event rates were calcu-
lated by dividing the Kaplan-Meier event rates by mean number of years follow-up.
Subsequently, Cox regression analysis for the primary and secondary endpoint was used 
to determine the prognostic value of coronary vessel dominance and CAD on CTA. The 
number of covariables included in the multivariate analysis was adjusted to the number 
of events. According to univariate significance and baseline differences between groups, 
age, smoking and diabetes were included in the multivariate model, together with the 
confounding factors gender and known CAD. The increase in global chi-square value was 
used to determine the incremental prognostic value of coronary vessel dominance over 
CAD on CTA and clinical risk factors. To avoid potential of overfitting in this extensive 
multivariate Cox regression model, two additional models were created only correcting 
for age, gender and overall plaque burden (model 1) and for age, gender and proximally 
located CAD (model 3). Furthermore, the prognostic value of significant stenosis location 
was determined for all patients, patients with right dominant coronary artery system and 
patients with left dominant coronary artery system. Adjusted hazard ratios (HR) with 95% 
confidence intervals (CIs) were reported. Statistical analysis was performed using SPSS 






The study population consisted of 1467 consecutive patients clinically referred for CTA at 
the Leiden University Medical Center (n=999, 68%) and at the University Hospital Zurich 
(n=468, 32%). In the total population the CTA examination was uninterpretable due to 
poor image quality in 42 (2.9%) patients. As a result, a total of 1425 patients (57±12 years 
old, 58% men) remained for analysis. In total, 1256 patients (88%) had a right dominant 
coronary artery system, while 131 patients (9.2%) had a left dominant and 38 patients 
(2.7%) had a balanced coronary artery system. The baseline characteristics of the patient 
population, categorized by coronary vessel dominance, are presented in Table 1. Overall 
baseline characteristics were similar between groups, although significant differences were 
observed for the presence of diabetes (22%, 34% and 45% for right, left and balanced 
coronary artery system, respectively, p=0.003).












Gender (male) 824 (58%) 733 (58%) 74 (57%) 17 (45%) 0.233
age (years) 57 ± 12 57 ± 12 56 ± 12 54 ± 15 0.095
reason for referral
Typical chest pain 213 (15%) 190 (15%) 18 (14%) 5 (13%) 0.870
Atypical chest pain and elevated risk profile 1212 (85%) 1066 (85%) 113 (86%) 33 (87%) 0.870
Clinical risk factors
Diabetes 338 (24%) 276 (22%) 45 (34%) 17 (45%) 0.003
Hypercholesterolemiaa 551 (39%) 495 (39%) 44 (34%) 12 (32%) 0.232
Hypertensionb 683 (48%) 599 (48%) 61 (47%) 23 (61%) 0.299
Family history of CADc 543 (38%) 476 (38%) 51 (39%) 16 (42%) 0.894
Current Smoking 354 (25%) 302 (24%) 43 (33%) 9 (24%) 0.102
Obesity (BMI ≥30 kg/m2) 257 (18%) 222 (19%) 24 (18%) 11 (29%) 0.227
known Cad
Previous myocardial infarction 126 (8.8%) 116 (9.2%) 8 (6.1%) 2 (5.3%) 0.357
Previous PCI 155 (11%) 140 (11.1%) 10 (7.6%) 5 (13.2%) 0.423
Data are presented as mean values ± SD or n (%).
a Serum total cholesterol ≥230 mg/dl and/or serum triglycerides ≥200 mg/dl or treatment with lipid 
lowering drugs
b Defined as systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg and/or 
the use of antihypertensive medication
c Defined as presence of coronary artery disease in first degree family members at <55 years in men 
and <65 years in women
BMI: body mass index; CAD: coronary artery disease; PCI: percutaneous coronary intervention.
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Follow-up was obtained for 1347 (94.5%) patients, while 78 (5.5%) patients were lost 
to follow-up. The distribution of coronary vessel dominance was comparable between 
patients with and without complete follow-up. Furthermore, patients lost to follow-up 
were younger (53±11 years old), had less hypertension (28.2%) and diabetes (9.0%) and 
were less often known with CAD (3.8%) compared to patients with follow-up.
CTA Results
CTA was classified as normal CTA or minor wall irregularities < 30% in 503 (35%) patients, 
non-significant CAD in 479 (34%) patients, and significant CAD in 443 (31%) patients 
(Table 2). Of those patients with significant CAD on CTA, 246 patients had 1-vessel disease, 
125 patients had 2-vessel disease and 72 patients were diagnosed with 3-vessel disease. 
Furthermore, the distribution of significant CAD on CTA did not differ significantly among 
patients with a right dominant, left dominant and balanced coronary artery systems. 
However, normal CTA or minor wall irregularities <30% were observed less frequently in 
patients with right dominant coronary artery system compared to patients with a left domi-
nant and balanced coronary artery systems (34%, 44% and 45%, respectively, p=0.031) 













Normal CTA or minor wall irregularities (<30%) 503 (35%) 428 (34%) 58 (44%) 17 (45%) 0.031
Non-significant CAD on CTA (30-50%) 479 (34%) 428 (34%) 38 (29%) 13 (34%) 0.504
Significant CAD on CTA (>50%) 443 (31%) 400 (32%) 35 (27%) 8 (21%) 0.186
1 vessel disease (>50%) 246 (17%) 224 (18%) 18 (14%) 4 (11%) 0.268
2 vessel disease (>50%) 125 (8.7%) 110 (7.7%) 13 (9.9%) 2 (5.3%) 0.670
3 vessel disease (>50%) 72 (5.1%) 66 (5.3%) 4 (3.1%) 2 (5.3%) 0.548
significant stenosis location
RCA 217 (15%) 205 (16%) 9 (7.2%) 3 (8.0%) 0.020
LM 27 (1.9%) 25 (2.0%) 1 (0.8%) 1 (2.6%) 0.325
LAD 324 (23%) 290 (23%) 27 (21%) 7 (18%) 0.723
LCX 163 (11%) 140 (11%) 19 (15%) 4 (11%) 0.484
overall plaque burden
Mean number of diseased segments (>30%) 3.1 ± 3.5 3.2 ± 3.5 2.5 ± 3.2 3.6 ± 4.3 0.697
Mean number of proximal diseased segments 
(>30%)
1.3 ± 1.4 1.3 ± 1.4 1.1 ± 1.3
1.4 ± 1.5
0.071
Comparison of CTA results between coronary vessel dominance groups. Data are presented as mean 
values ± SD or n (%).
CAD: coronary artery disease; CTA: computed tomography coronary angiography; RCA: right coronary 
artery; LAD: left anterior descending artery; LCX: left circumflex artery; LM: left main artery.
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(Table 2). In addition, there was no difference in the extent of CAD, since the number of 
vessels affected and the overall plaque burden were comparable between groups (Table 2). 
Specifically looking at significant stenosis location, the prevalence of a significant stenosis 
in the RCA was higher in patients with right dominant coronary artery system as compared 
to patients with a left dominant and balanced coronary artery system (16%, 7% and 8%, 
respectively, p=0.020), while the prevalence of a stenosis in the LAD and LCX did not differ 
among groups (Table 2).
Cardiac events 
During a median follow-up time of 24 months (25th-75th percentile: 15-37 months), the 
composite endpoint occurred in 57 (4.0%) patients. Specifically, non-fatal myocardial 
infarction was reported in 18 (1.3%) patients, while cardiac death occurred in 9 (0.6%) 
patients and 30 (2.1%) patients died due to non-cardiac death. Causes of the 30 non-
cardiac deaths were malignancy (6 deaths), sepsis (5 deaths), respiratory insufficiency (4 
deaths), vascular events (3 deaths), post-operative non-cardiac complications (3 deaths) 
and other causes (7 deaths). In two cases the reason of death remained unknown. A 
total of 120 (8.4%) patients underwent revascularization, in 87 (6.1%) by percutane-
ous coronary intervention (PCI) and in 33 (2.3%) by CABG. No differences in referral for 
coronary revascularization after CTA were observed between the different coronary vessel 
dominance groups (revascularization rate of 8.6%, 7.6% and 5.3% in patients with right 
dominant, left dominant and balanced coronary artery systems respectively, p=0.706). 
Peri-procedural complications were observed in 4 (0.3%) patients. These 4 patients had 
a right dominant coronary artery system and experienced a non-fatal MI within 90 after 
revascularization by PCI.
Event rates during follow-up in relation to CAD on CTA and coronary vessel 
dominance
When comparing difference in event-free survival in the total study population according 
to coronary vessel dominance, the cumulative incidence of non-fatal myocardial infarction 
and all-cause mortality after 3 years of follow-up was 17% in patients with a left dominant 
coronary artery system, compared to 4.8% and 2.7% in patients with right dominant and 
balanced coronary artery systems, respectively (log-rank p<0.001, Figure 1). After stratifi-
cation according to the absence or presence of significant CAD on CTA, patients without 
significant CAD showed to have good prognosis with low annual event rates for adverse 
cardiac events of 0.3%, as well as low annual event rates for the composite of non-fatal 
MI and all-cause mortality of 0.9% (Table 3). Furthermore, in patients without significant 
CAD no significant difference was observed in event-free survival between right dominant 
and left dominant coronary artery systems, with cumulative event rates of 2.4% and 7.4% 
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figure 1. Kaplan Meier survival curve for non-fatal myocardial infarction and all-cause mortality in pa-
tients with right dominant, left dominant and balanced coronary artery system.
In the total study population statistically significant difference in event-free survival according to coro-
nary vessel dominance was observed, showing a worse outcome in patients with a left dominant coro-
nary artery system (log-rank p<0.001).
Table 3. Adverse (Cardiac) Events in patients with right and left dominant coronary artery systems strati-























Total 1387 38* (2.7%) 9 (0.7%) 18 (1.2%) 27 (1.9%) 1.0% 56 (4.0%) 1.9%
Right dominant 1256 27 (2.1%) 4 (0.3%) 14 (1.1%) 18 (1.4%) 0.8% 41 (3.3%) 1.6%
Left dominant 131 11 (8.4%) 5 (3.8%) 4 (3.1%) 9 (6.9%) 2.8% 15 (11.5%) 4.5%
Log-rank p value <0.001 0.061 0.047 <0.001 <0.001
no significant Cad 952 15 (1.6%) 2 (0.2%) 4 (0.4%) 6 (0.6%) 0.3% 19 (2.0%) 0.9%
Right dominant 856 12 (1.4%) 2 (0.2%) 3 (0.4%) 5 (0.6%) 0.3% 15 (1.8%) 0.8%
Left dominant 96 3 (3.1%) 0 (0.0%) 1 (1.0%) 1 (1.0%) 1.1% 4 (4.2%) 2.1%
Log-rank p value 0.151 0.445 0.301 0.563 0.106
significant Cad 435 23 (5.3%) 7 (1.6%) 14 (3.2%) 21 (4.8%) 2.2% 37 (8.5%) 3.8%
Right dominant 400 15 (3.8%) 2 (0.5%) 11 (2.8%) 13 (3.3%) 2.0 % 26 (6.5%) 3.2%
Left dominant 35 8 (23%) 5 (14%) 3 (8.6%) 8 (23%) 7.9 % 11 (31%) 9.9%
Log-rank p value <0.001 0.010 0.059 <0.001 <0.001
Annual event rates were calculated by dividing the Kaplan-Meier event rates by mean number of years 
follow-up. Patient with balanced coronary artery system were excluded from the analysis. *One patient 
with balanced coronary artery system without significant CAD on CTA died because of non-cardiac 
death, accordingly in the total population of 1425 patients 39 patients died.




after 3 years of follow-up for right and left dominant coronary artery system, respectively 
(log-rank p=0.106; Figure 2A).
figure 2. Kaplan Meier curve for non-fatal myocardial infarction and all-cause mortality in patients with 
right dominant and left dominant coronary artery system, stratified for the presence of significant CAD 
on CTA.
a: Patients without significant CAD on CTA. b: Patients with significant CAD on CTA. Patients with bal-
anced coronary artery system were excluded from the analysis, because of the low number of patients 
in this group. Patients without significant CAD on CTA (A) had good event-free survival, showing no 
statistically significant difference in event-free survival between patients with a left dominant and a right 
dominant coronary artery system in this patient category (log-rank p=0.106). In the subgroup patients 
with significant CAD on CTA (B), patients with a left dominant coronary artery system had statistically 
significant worse outcome compared to patients with a right dominant coronary artery system (log-rank 
p<0.001).
CAD coronary artery disease; CTA computed tomography coronary angiography.
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However, in patients with significant CAD higher annual event rates were observed for 
adverse cardiac events and the composite of non-fatal MI and all-cause death of 2.2% and 
3.8%, respectively (Table 3). In addition, in the subgroup of patients with significant CAD 
differences in prognosis were observed between patients with right dominant and left 
dominant coronary artery system, because patients with a left dominant coronary artery 
system showed a significantly worse outcome with a cumulative incidence of non-fatal 
MI and all-cause mortality of 35% compared to 9.5% in patients with a right dominant 
coronary artery system within a follow-up period of 3 years (log–rank p<0.001; Figure 2B).
Incremental prognostic value 
The incremental value of coronary vessel dominance and CAD on CTA was assessed for 
non-fatal MI and all-cause mortality (Table 4). Left dominant coronary artery system was 
identified as a significant predictor of the primary endpoint and remained a significant pre-
dictor after correction for baseline risk factors and CAD on CTA, with a HR of 3.20 (95% CI 
1.67-6.13, p<0.001). Balanced coronary artery system did not predict for events (HR 0.82; 
95%CI 0.11-6.05, p=0.842). In addition, significant CAD in 1 vessel was also identified 
as a predictor for non-fatal MI and all-cause mortality, with a HR of 2.79 (95%CI 1.03-
7.60, p=0.045). Subsequently, the risk was increased when more vessels were diseased, 
Table 4. Multivariate Cox regression analysis for the composite endpoint of non-fatal myocardial infarc-
tion and all-cause mortality including clinical risk factors, CTA results and coronary vessel dominance
hr (95%-CI) p-value
Clinical risk factors
Age 1.06 (1.03-1.08) <0.001
Gender (male) 1.33 (0.76-2.33) 0.320
Known CAD 1.25 (0.65-2.40) 0.506
Smoking 3.03 (1.79-5.12) <0.001
Diabetes 1.53 (0.86-2.72) 0.146
CTa results
Normal CTA or minor wall irregularities (<30%) 1.0 (reference)
Non-significant CAD (30-50%) 1.44 (0.53-3.88) 0.473
1-vessel disease (>50%) 2.79 (1.03-7.60) 0.045
2-vessel disease (>50%) 3.59 (1.24-10.40) 0.019
3-vessel disease (>50%) 4.14 (1.31-13.06) 0.016
Coronary vessel dominance 
Right dominant coronary artery system 1.0 (reference)
Left dominant coronary artery system 3.20 (1.67-6.13) <0.001
Balanced coronary artery system 0.82 (0.11-6.05) 0.842
CAD: coronary artery disease; CI: confidence interval; CTA: computed tomography coronary angiogra-
phy; HR: hazard ratio.
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with a HR of 3.59 (95%CI 1.24-10.40, p=0.019) and a HR of 4.14 (95%CI 1.31-13.06, 
p=0.016) for 2- and 3-vessel disease, respectively. No interaction was observed for the 
effect of right dominant versus left dominant coronary artery system and the absence 
versus the presence of significant CAD on CTA for non-fatal MI and all-cause mortality 
(p-value for interaction=0.227). Furthermore, a significant increase in global chi-square 
values confirmed that CAD on CTA had incremental value over clinical risk factors (53.05 
vs. 36.32, p=0.025) and that coronary vessel dominance had incremental value over CAD 
and clinical risk factors (65.53 vs. 52.05, p=0.006) (Figure 3). Additionally, in reduced Cox 
regression models left dominant coronary artery system remained a significant predictor 
for non-fatal MI and all-cause mortality with comparable risk estimates, when correcting 
for overall plaque burden (model 1), proximally located CAD (model 2) and the number 
of vessels with significant stenosis on CTA (Table 5). Subsequently, overall plaque burden, 
proximally located CAD and the number of vessels affected were identified as predictors 
of non-fatal MI and all-cause mortality with the highest HR of 1.68 (95% CI 1.32-2.14, 
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figure 3. Bar graph illustrating the incremental prognostic value (depicted by χ2 values on the y-axis) of 
clinical risk factors, CTA results and coronary vessel dominance.
The presence of significant CAD on CTA had a significant incremental prognostic value over the clinical 
risk factors age, gender, known CAD, smoking and diabetes (p=0.025). A further incremental prognostic 
value over clinical risk factors and significant CAD on CTA was observed with the addition of coronary 
vessel dominance (p=0.006). The CTA results included in the model consisted of the 5 categories: normal 
coronaries or minimal wall irregularities (< 30%), non-obstructive CAD (30-50%) and 1-, 2-, and 3-vessel 
disease (>50%).
CAD: Coronary artery disease; CTA: computed tomography coronary angiography.
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In addition, sub-analysis assessing the independent prognostic value of coronary vessel 
dominance for the occurrence of non-fatal MI and cardiac death (extensive analysis is not 
shown) revealed that a left dominant coronary artery system remained a significant predic-
tor of cardiac events (hazard ratio between 5.13 and 5.66 when corrected for significant 
CAD, overall plaque burden or proximally located CAD, all analyses p<0.001).
Prognostic value of significant stenosis location 
A stenosis in the left coronary system was observed in 222 patients and was associated 
with an increased risk of non-fatal myocardial infarction and all-cause mortality, with a 
HR of 2.79 (95%CI 1.46-5.31, p=0.002) (Table 6). In case of a stenosis in both (right and 
left) coronary systems, as was present in 150 patients, a HR of 3.05 (95%CI 1.47-6.31, 
p=0.003) was observed. A significant stenosis in the right coronary system, as observed in 
63 patients, was not significantly associated with the composite endpoint. Furthermore, in 
patients with a right dominant coronary artery system, a stenosis in the left coronary system 
and a stenosis in both (right and left) coronary systems were associated with an increased 
Table 5. Reduced cox regression models of age and gender, CTA results and coronary vessel dominance 
for the composite endpoint of non-fatal myocardial infarction and all-cause mortality
hr (95%-CI) p-value
model 1 : overall Plaque burden on CTa
Age 1.05 (1.02-1.08) <0.001
Gender 1.28 (0.71-2.30) 0.406
Number of segments diseased (>30%) 1.14 (1.06-1.23) <0.001
Left dominant coronary artery system 3.97 (2.11-7.50) <0.001
model 2: Proximally located Cad on CTa
Age 1.04 (1.01-1.07) 0.004
Gender 1.32 (0.74-2.36) 0.341
Proximal diseased segments (>30%) 1.48 (1.20-1.83) <0.001
Left dominant coronary artery system 3.77 (2.00-7.10) <0.001
model 3: Extent of significant Cad on CTa
Age 1.04 (1.02-1.07) 0.002
Gender 1.45 (0.82-2.56) 0.199
Number of vessels with significant stenosis (>50%) 1.68 (1.32-2.14) <0.001
Left dominant coronary artery system 3.72 (1.98-6.99) <0.001
Overall plaque burden was assessed by the number of diseased segments including all plaques caus-
ing >30% luminal narrowing (model 1). Proximally located CAD was defined as non-significant and 
significant stenosis in all proximally located segments (model 2). The number of vessels with significant 
stenosis (>50%) included 1-, 2- and 3-vessle disease and was entered into the models as a continuous 
variable (model 3).
CAD: coronary artery disease; CI: confidence interval; CTA: computed tomography coronary angiogra-
phy; HR: hazard ratio.
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risk of events with a HR of 2.41 (95%CI 1.14-5.12, p=0.022) and a HR of 3.12 (95%CI 
1.40-6.98, p=0.006), respectively. Subsequently, in patients with a left dominant coronary 
artery system, a stenosis in the left coronary system was associated with an increased risk 
of non-fatal MI and all-cause death, with a HR of 5.00 (95%CI 1.35-18.43, p=0.016). The 
difference in the risk-estimate of a stenosis in the left coronary system in patients with a 
right dominant and patients with a left dominant coronary artery system was statistically 
non-significant (HR of 2.4 and HR of 5.0, respectively, p-value for interaction=0.351).
Table 6. Cox Regression analysis of significant stenosis location for non-fatal myocardial infarction and 




hr (95%-CI) p-value hr (95%-CI) p-value
all patients 1387
No significant CAD (<50%) 952 1.0 (reference) 1.0 (reference)
Significant stenosis in the right coronary systema 63 3.11 (1.07-9.08) 0.037 2.25 (0.76-6.65) 0.142
Significant stenosis in the left coronary systemb 222 3.54 (1.90-6.59) < 0.001 2.79 (1.46-5.31) 0.002
Significant stenosis in both coronary systemsc 150 4.20 (2.10-8.39) < 0.001 3.05 (1.47-6.31) 0.003
Patients with right dominant coronary artery 
system 
1256
No significant CAD (<50%) 856 1.0 (reference) 1.0 (reference)
Significant stenosis in the right coronary system 61 1.94 (0.45-6.65) 0.376 1.48 (0.34-5.12) 0.602
Significant stenosis in the left coronary system 196 3.20 (1.54-6.65) 0.002 2.41 (1.14-5.12) 0.022
Significant stenosis in both coronary systems 143 4.44 (2.06-9.57) < 0.001 3.12 (1.40-6.98) 0.006
Patients with left dominant coronary artery 
system
131
No significant CAD (<50%) 96 1.0 (reference) 1.0 (reference)
Significant stenosis in the right coronary system† 2 - -
Significant stenosis in the left coronary system 26 5.30 (1.49-18.82) 0.010 5.00 (1.35-18.43) 0.016
Significant stenosis in both coronary systems 7 5.68 (1.03-31.42) 0.046 4.81 (0.85-27.16) 0.075
Patients with balanced coronary artery system were excluded from the analysis. Multivariate analysis 
correcting for age and gender was performed. Patients without significant CAD on CTA were consid-
ered the reference group. aStenosis in the right coronary system = at least one significant stenosis in the 
RCA. bStenosis in the left coronary system = at least one significant stenosis in the LM, LAD and/or LCX. 
cStenosis in both coronary systems = at least one significant stenosis in the RCA and the LM, LAD and/
or LCX. †Hazard ratio’s could not be calculated for patients with left dominant coronary artery system 
and a stenosis in the right coronary system, due to the very small number of patients within this group.
CAD: coronary artery disease; CI: confidence interval; HR: hazard ratio; LAD: left anterior descending 
artery; LCX: left circumflex artery; LM: left main artery; RCA: right coronary artery.
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dIsCussIon
This study demonstrated that coronary vessel dominance assessed by CTA has incremental 
prognostic value and extends the predictive value of CTA. The main findings of the study 
were that the presence of a left dominant coronary artery system is associated with an 
increased risk of non-fatal myocardial infarction and all-cause mortality as compared to 
a right dominant coronary artery system. Moreover, the presence of significant CAD on 
CTA in patients with a left dominant coronary artery system was associated with worse 
outcome than significant CAD on CTA in patients with a right dominant coronary artery 
system. These findings suggest that the assessment of coronary vessel dominance using 
CTA may further enhance the risk stratification beyond the assessment of degree of steno-
sis in patients referred for CTA.
The prognostic value of significant CAD using CTA is well established, and an increased 
risk of cardiovascular events in patients with significant CAD on CTA has been previ-
ously demonstrated4-6,18,19. These findings are confirmed in the present study, showing 
a higher risk of events in patients with significant CAD on CTA, regardless of coronary 
vessel dominance. While coronary vessel dominance is routinely assessed using CTA, 
limited information is available about the prognostic value of coronary vessel dominance 
in patients referred for CTA. A previous study by Goldberg et al. showed that in a large 
cohort of patients (n=27,289) who underwent cardiac catheterization due to acute coro-
nary syndrome the presence of a left dominant coronary artery system was a predictor 
of death at a mean follow-up duration of 3.5 years (HR 1.18, 95%CI 1.05-1.34)20. The 
prognostic value of coronary vessel dominance was most pronounced in patients with 
acute ST-segment elevation myocardial infarction. Remarkable is that the hazard of the 
presence of a left dominant coronary artery system was less pronounced in the study by 
Goldberg et al. compared to the hazard observed in the current study (HR 3.20, 95%CI 
1.67-6.13). However, the study population may have differed substantially between our 
investigation and the one by Goldberg et al. The event rate in the study population of 
Goldberg et al. was higher in all coronary vessel dominance groups since their population 
consisted of high risk patients, as compared to low to intermediate risk patients in our 
population. Because of the overall worse prognosis in all patients, the difference between 
groups could be less pronounced. Furthermore, the outcome measure of Goldberg et al. 
was all-cause mortality, whereas in the present study also non-fatal MI was included as a 
primary endpoint in addition to all-cause mortality. These differences in study population 
and outcome are expected to account for the difference in findings between studies. Im-
portantly, the prognostic value of coronary vessel dominance in patients with and without 
significant CAD was evaluated in the present study. Patients without significant CAD on 
CTA showed to have a good prognosis irrespective of coronary vessel dominance. These 
findings confirm the excellent prognostic value of a CTA examination without significant 
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CAD21. In addition, this study showed that in patients with significant CAD on CTA the 
presence of a left dominant coronary artery system significantly increased the risk of non-
fatal MI and all-cause mortality as well as for adverse cardiac events including cardiac death 
as confirmed by sub-analysis.
The extent of atherosclerosis in relation to coronary vessel dominance 
Although limited information is currently available regarding the prognostic value of 
coronary vessel dominance, the relationship between coronary vessel dominance and 
anatomical variance of the coronary arteries was investigated in several different studies. A 
study by Dodge et al., evaluating 83 invasive coronary angiograms, demonstrated a smaller 
RCA diameter and a larger LCX diameter in patients with a left dominant coronary artery 
system22. In addition, Ilia et al. found that a long LAD (defined as a LAD wrapped around 
the apex of the heart) was present in 87% of patients with left dominant coronary artery 
system compared to 47% of patients with a right dominant coronary artery system23.
Furthermore, the relation between coronary vessel dominance and the extent of CAD 
remains uncertain as different studies showed opposing results. The aforementioned study 
by Goldberg et al. showed more extensive CAD in patients with a right dominant coronary 
artery system as compared to patients with a left dominant coronary artery system20. Simi-
lar findings were shown in the study by Vasheghani-Farahani et al., identifying a higher 
prevalance of three-vessel disease in patients with right dominant coronary artery system24. 
However, Balci et al. did not find a significant difference in the extent of significant CAD 
between patients with a right and left dominant coronary artery system25. Though the 
current study did not reveal significant differences in the distribution of significant CAD 
on CTA, normal CTA results or wall irregularities causing less than 30% luminal narrow-
ing were observed less frequently in patients with right dominant coronary artery system 
compared to patients with left dominant and balanced coronary artery systems. Still, for 
the determination of the relationship between the extent of significant CAD and coronary 
vessel dominance, more extensive research is required in larger patient populations.
Underlying mechanisms
At present, little is known about the prognostic value of significant stenosis location in 
relation to coronary vessel dominance. This study demonstrated that a stenosis in the left 
coronary system, meaning the LAD and/or LCX, was associated with an increased risk 
of events, while a stenosis in the RCA did not statistically significant predict events. The 
hazard of a stenosis in the left coronary system was comparable between patients with a 
right dominant and left dominant coronary artery system. Still, coronary vessel dominance 
has influence on the relative contribution of the different coronary arteries to the total left 
ventricular blood flow23,26. The anatomic importance of a significant stenosis in patients 
with left dominant coronary artery system might be different than that in patients with 
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a right dominant or balanced coronary artery system. In risk scores the weight factors 
for a significant stenosis in the segments of the coronary tree differ for patients with a 
right and a left dominant coronary artery system, with higher scores for the segments of 
the LAD and LCX in patients with a left dominant coronary artery system26. In patients 
with a left dominant coronary artery system, the left ventricle receives almost the entire 
blood supply from the LAD and the LCX, possibly resulting in more extensive myocardial 
infarction, in case of an significant stenosis in these vessels. Moreover, the possibility to 
form collaterals might be less in patients with a left dominant coronary artery system. 
Since the PDA originating from the RCA is lacking, no collaterals can be formed from the 
right coronary system, when the left coronary system is suffering from a severe stenosis. 
At present, however, no studies are available investigating the relation between coronary 
vessel dominance and severity of myocardial infarction or coronary collateral circulation 
formation. Therefore, further research is needed to identify factors contributing to the 
inferior prognosis of patients with left dominant coronary artery system.
Clinical implication
In patients referred for CTA, left dominant coronary artery system was identified as a 
significant risk factor for myocardial infarction and death. Particularly in the subgroup of 
patients with significant CAD on CTA, those patients with a left dominant coronary artery 
system had a strongly increased risk of events compared to patients with a right dominant 
coronary artery system. Therefore, the potential indication for intensive treatment could 
be more prominent in patients with left dominant coronary artery system. Furthermore, in 
case of uncertainty about the need for referral for revascularization, subsequent testing for 
ischemia might reveal important information that may assist in clinical decision making. In 
current clinical practice no clear distinction is made in the treatment strategies between 
patients with a right dominant and a left dominant coronary artery system. When other 
studies will confirm the results of our study, the knowledge of the prognostic impact of 
coronary vessel dominance might affect choice of treatment. Accordingly, the evaluation 
of coronary vessel dominance could assist in clinical decision making and prognostication 
in patients referred for CTA.
Limitations
The current study has several limitations. First, the study was conducted in a relatively 
small patient population, which results in a comparatively small group of patients with 
a left dominant coronary artery system, and an even smaller group for patients with a 
balanced coronary artery system. Of note, the prevalence of right dominant, left dominant 
and balanced coronary artery system in the present study population is comparable with 
that described in previous literature9. Because of the small patient groups among patients 
with significant CAD on CTA, statistically significant difference between the risk estimates 
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for having a significant stenosis in the left coronary system in patients with a right and a 
left dominant coronary artery system was not observed, presumably due to insufficient 
power. Larger studies are needed to elucidate the relationship between significant stenosis 
location and coronary vessel dominance. Second, plaque composition, which may have 
impact on outcome as well, was not evaluated. In addition, to what extent severely calci-
fied plaques may potentially have influenced the assessment of stenosis severity remains 
unknown. Third, the multivariate Cox regression model in the current analysis was at the 
edge of overfitting, due to a relatively low number of clinical events in the present study. 
However, the confidence intervals observed in the Cox regression analysis were considered 
reliable and reduced Cox regression models could confirm the prognostic value of coronary 
vessel dominance. Fourth, 5.5% of patients were lost to follow-up. However, no difference 
in the distribution of coronary vessel dominance was observed in patients without follow-
up. Fifthly, because of the relatively low event rate in the current study, larger studies are 
needed to evaluate the effect of coronary vessel dominance on cardiac adverse events like 
the composite of non-fatal MI and cardiac death. Instead, the composite of non-fatal MI 
and all-cause mortality was the primary endpoint in the current study. Subsequently, future 
studies in larger patient cohorts are warranted to confirm these findings.
ConClusIons
The presence of a left dominant coronary artery system is associated with an increased risk 
of non-fatal myocardial infarction and all-cause mortality. Furthermore, coronary vessel 
dominance has significant incremental prognostic value over clinical risk factors and signifi-
cant CAD on CTA. In addition, the presence of significant CAD on CTA in patients with a 
left dominant coronary artery system is associated with worse outcome than the presence 
of significant CAD in patients with a right dominant coronary artery system. Therefore, the 
assessment of coronary vessel dominance may further enhance risk stratification beyond 
the assessment of severity and extent of CAD on CTA. However, the underlying mechanism 
is unknown and its application therefore remains speculative.
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Influence of coronary vessel dominance on 
short-and long-term outcome in patients after 
ST-segment elevation myocardial infarction.
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Prognostic importance of coronary vessel dominance in patients with ST-elevation myocar-
dial infarction (STEMI) remains uncertain. The aim of this study was to assess influence of 
coronary vessel dominance on the short- and long-term outcome after STEMI.
Methods and Results: 
Coronary angiographic images of consecutive patients presenting with first STEMI were 
retrospectively reviewed to assess coronary vessel dominance. Patients were followed after 
STEMI during a median period of 48 (IQR 38-61) months for the occurrence of all-cause 
mortality and the composite of reinfarction and cardiac death. The l population comprised 
1131 patients of which 971 (86%) patients had a right dominant system, 102 (9%) a 
left dominant system and 58 (5%) a balanced system. After 5 years of follow-up the 
cumulative incidence of all-cause mortality was significantly higher in patients with a left 
dominant system, compared to a right dominant and balanced system (log-rank P=0.013). 
Moreover, a left dominant system was an independent predictor for 30-day mortality (OR 
2.51, 95% CI 1.11-5.67, P=0.027) and the composite of reinfarction and cardiac death 
within 30-days after STEMI (OR 2.25, 95%CI 1.09-4.61, P=0.028). In patients surviving first 
30-days post-STEMI, coronary vessel dominance had no influence on long-term outcome.
Conclusions: 
A left dominant coronary artery system is associated with a significantly increased risk of 
30-day mortality and early reinfarction after STEMI. After surviving the first 30-days post-
STEMI, coronary vessel dominance had no influence on long-term outcome.
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InTroduCTIon
Coronary vessel dominance, defined by the coronary artery that supplies the posterior 
descending artery(PDA) and posterolateral branches, influences the relative contribution 
of the different coronary arteries to the total left ventricular blood flow.1 A right dominant 
system has a reported prevalence of 87-89%.2-4 In patients with a left dominant system ap-
proximately 60% of the left ventricular myocardium is supplied by the PDA and posterolat-
eral branches originating from the LCx.5 This less well-balanced coronary circulation might 
have a negative influence on prognosis of patients with coronary artery disease (CAD). 
Currently, the prognostic importance of coronary vessel dominance in patients presenting 
with first ST-segment elevation myocardial infarction (STEMI) remains uncertain. The aim 
of this study was to assess the influence of coronary vessel dominance on the 30-day 
mortality and long-term outcome after STEMI.
mEThods 
Patients 
The population consisted of consecutive patients presenting with first STEMI at the Leiden 
University Medical Center between 2004 and 2008. Patients with previous myocardial in-
farction, previous percutaneous coronary intervention (PCI) and/or previous coronary artery 
bypass grafting were excluded. The diagnosis STEMI was defined based on criteria of typical 
chest pain, elevated cardiac enzyme levels, and typical changes on the electrocardiogram.6 
All patients were treated according to the institutional MISSION! Protocol,7 based upon the 
European Society of Cardiology and American College of Cardiology/American Heart As-
sociation guidelines.8,9 The protocol includes primary PCI, optimal medical therapy initiated 
early during hospitalization and two-dimensional echocardiography performed within 48 
hours of admission to assess residual left ventricular function.10 
Demographic, clinical, angiographic and echocardiographic data were prospectively col-
lected in the departmental Cardiology Information System (EPD-Vision®, Leiden University 
Medical Center, Leiden, The Netherlands) and retrospectively analyzed. Patients with un-
interpretable coronary angiographic images for coronary vessel dominance were excluded 
from analysis.
Primary percutaneous coronary intervention and angiographic data 
analysis
Images of the coronary angiography and PCI were obtained using standardized angiographic 
projections according to the guidelines of the American College of Cardiology/American 
Heart Association,11 and stored digitally. All images were retrospectively reviewed by two 
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experienced observers. During e analysis coronary vessel dominance, the culprit vessel and 
culprit lesion and severity of coronary artery disease (CAD) were recorded. A coronary artery 
system was classified as right dominant if the PDA and posterolateral branch originated 
from the RCA, left dominant if the PDA and the posterolateral branch originated from the 
LCx artery, and balanced if the PDA originated from the RCA in combination with pos-
terolateral branches originating from the LCx artery.4,12 The culprit vessel was determined 
on the coronary artery territory subtended by the regions of acute electrocardiographic 
changes. If the culprit vessel had more than two lesions, the most severe proximal stenosis 
or a stenosis identified with thrombus was considered the culprit lesion.13 The extent of 
CAD was expressed as the presence of one-, two- or three-vessel disease (stenosis causing 
≥50% luminal narrowing). Complete revascularization was defined as treating all present 
significant coronary artery stenosis (≥70% luminal narrowing) during primary PCI or during 
secondary revascularization before discharge.
Follow-up and endpoint definitions 
After discharge, patients were followed according to the institutional STEMI protocol.7,14 
By reviewing medical records, retrieval of survival status through municipal civil registries 
and telephone interviews, data on the occurrence of adverse events after discharge were 
collected. The adverse events included nonfatal reinfarction and all-cause mortality dur-
ing follow-up. Nonfatal reinfarction was defined based on criteria of typical chest pain, 
elevated cardiac enzyme levels and typical changes on the electrocardiogram.6 The primary 
cause of death was recorded and all deaths were classified as cardiac unless unequivocally 
proven non-cardiac.
The primary endpoint was all-cause mortality. The secondary endpoint was the com-
posite of reinfarction and cardiac death. Short- and long-term outcome after STEMI were 
investigated using these endpoints. Short-term outcome was defined as within the first 30 
days post-STEMI.
Follow-up was updated regularly until 2012. Patients with <2 years of follow-up after 
STEMI, but who were alive according to the municipal civil registries, were considered lost 
to follow-up. Data of these patients were included up to the last date of follow-up.
Statistical analysis
Continuous variables are presented as mean ± standard deviation or as median and 
interquartile range. Categorical variables are presented as number and percentages. Dif-
ferences in baseline characteristics between the three coronary vessel dominance groups 
were evaluated with one-way analysis of variance (ANOVA) and chi-squared tests, where 
appropriate. To estimate the cumulative incidences of the primary and secondary endpoint 
during long-term follow-up Kaplan-Meier analyses stratified for coronary vessel dominance 
was performed. In addition, to investigate the difference in short-term outcome between 
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the different coronary vessel dominance groups multivariate binary logistic regression 
analysis was performed with the endpoints 30-day mortality and the occurrence of re-
infarction within 30-days post-STEMI. The number of covariables included in the analysis 
was adjusted to the number of events and complete availability, resulting in inclusion of 
the clinical risk factors age, gender, diabetes, hypertension and smoking. The results of the 
binary logistic regression analysis were reported as adjusted odds ratios (OR’s) with 95% 
confidence intervals (CIs). Subsequently, the influence of coronary vessel dominance on 
long-term outcome was evaluated using Cox regression analysis in a subgroup of patients 
surviving the first 30 days after STEMI. In the multivariate Cox regression model the covari-
ables were selected based upon univariate significance of P-value ≤0.20 and/or significant 
difference in baseline distribution among the vessel dominance groups, resulting in inclu-
sion age, gender, diabetes, hypertension, smoking, Killip class during STEMI, three-vessel 
disease, peak cardiac troponin T, glomerular filtration rate (eGFR), left-ventricular ejection 
fraction and finally reinfarction within the first 30 days post-STEMI was corrected for to 
adjust for its effect on long-term outcome in the survivors of the 30 days post-STEMI. The 
results of the Cox regression analysis were reported as adjusted hazard ratios (HRs) with 
95% Cis. Statistical analysis was performed using SPSS software (version 20.0, SPSS, Inc., 
Chicago, IL, USA). A P-value of <0.05, by a two-sided test, was considered statistically 
significant.
rEsulTs 
Patient and angiographic characteristics
A total of 1156 consecutive patients were included. Twentyfive patients (2%) were 
excluded from the analysis due to uninterpretable coronary vessel dominance. The final 
population comprised 1131 patients of which 971 (86%) patients had a right dominant 
system, 102 (9%) patients had a left dominant system and 58 (5%) patients had a bal-
anced system. The patients characteristics and angiographic data are presented in Table 1. 
Overall baseline characteristics were similar between coronary vessel dominance groups. 
However, patients with a balanced system tended to be younger (p=0.026) and patients 
with a left dominant system more frequently had hypertension (p=0.036). The RCA was 
most often the culprit vessel in patients with a right dominant system, whereas in patients 
with a left dominant or balanced system the LAD artery was most often the culprit vessel. 
Moreover, a relatively high incidence of the LCx as culprit vessel was observed in patients 
with a left dominant system (P<0.001). Importantly, the majority of patients presented with 
single vessel disease. Complete revascularization was achieved in 789 patients (70%). A 
trend towards a slightly lower left ventricular ejection fraction at discharge was observed 




Follow-up was completed in 1076 patients (95%), with 55 patients (5%) lost to follow-up. 
The median follow-up was 48 months (IQR 38-61). The primary endpoint occurred in 119 
patients (11%): 77 patients (7%) died from cardiac death and 42 patients (4%) died from 
non-cardiac causes. Furthermore, 92 patients (8%) had reinfarction, of which 9 were fatal. 
The secondary endpoint occurred in 154 patients (14%).
The cumulative incidence of both the primary and secondary endpoint after 5 years 
post-STEMI was higher in patients with a left dominant system (Figure 1).












Gender (male) 850 (75%) 731 (75%) 73 (72%) 46 (79%) 0.536
Age (years) 61±12 61±12 63±13 58±11 0.026*
Diabetes 117 (10%) 96 (10%) 12 (12%) 9 (16%) 0.351
Hypercholesterolemia 191 (17%) 160 (17%) 22 (22%) 9 (16%) 0.414
Hypertension 361 (32%) 304 (31%) 43 (42%) 14 (24%) 0.036
Current smoking 549 (49%) 468 (48%) 48 (47%) 33 (57%) 0.426
Presenting in Killip class ≥2 during STEMI 66 (6%) 54 (6%) 7 (7%) 5 (9%) 0.574
Culprit vessel
LM 7 (0.6%) 6 (0.6%) 1 (1%) 0 (0%) 0.749
RCA 438 (39%) 421 (43%) 3 (3%) 14 (24%) <0.001
LAD 512 (45%) 418 (43%) 62 (61%) 32 (55%) 0.001
LCx 174 (15%) 126 (13%) 36 (35%) 12 (21%) <0.001
Extent of Cad
One-vessel disease 606 (54%) 515 (53%) 59 (58%) 32 (55%) 0.632
Two-vessel disease 350 (31%) 305 (31%) 31 (30%) 14 (24%) 0.504
Three-vessel disease 175 (16%) 151 (16%) 12 (12%) 12 (21%) 0.319
Complete revascularization 789 (70%) 684 (70%) 69 (68%) 36 (62%) 0.358
eGFR(mL/min/1.73m2) 100±34 100±35 97±34 106±28 0.220
eGFR ≤60 mL/min/1.73m2 131 (12%) 115 (12%) 13 (13%) 3 (5%) 0.276
Peak cardiac troponin T level(μg/L) 6.1±6.5 6.1±6.4 6.4±6.8 6.5±6.7 0.543
Peak cardiac troponin T level ≥3.5 μg/L 627 (56%) 539 (56%) 55 (54%) 33 (57%) 0.967
LV ejection fraction at discharge(%) 47±9 47±9 45±9 49±10 0.053
LV ejection fraction≤40% 235 (22%) 200 (22%) 22 (24%) 13 (24%) 0.853
* left dominant versus balanced coronary artery systems.
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Coronary vessel dominance and 30-day adverse outcome 
Among 119 patients who died, 45 patients (4%) died within the first 30 days after STEMI 
of which 25 patients (56%) died within 24 hours after STEMI. The majority was classified as 
cardiac death (43 of the 45 patients: cardiogenic shock (20 patients), ventricular fibrillation 
(3 patients), left ventricular free wall rupture (4 patients), heart failure (9 patients), reinfarc-
tion due to instent restenosis (4 patients) or undetermined (3 patients). Two patients were 
classified as non-cardiac death as they died due to an infection after coronary bypass 
surgery and a gastro-intestinal bleeding after PCI. Furthermore, 24 patients (2%) had 
reinfarction within the first 30 days after STEMI. The secondary endpoint was reached in 
63 patients (5.5%) at 30-days post-STEMI.
figure 1. Kaplan-Meier curves for the primary and secondary endpoint in the total patient population 
stratified according to coronary vessel dominance.
Patients with left dominant coronary artery system had statistically significant worse outcome with higher 
cumulative incidence of all-cause mortality (A, log-rank P=0.013) and higher cumulative incidence of the 
composite of reinfarction and cardiac death (B, log-rank P=0.007) during long-term follow-up after STEMI.
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Patients who died within 30 day post-STEMI were more likely to be female, of advanced 
age and less likely to smoke (Table 2). Furthermore, these patients presented with a higher 
Killip class during STEMI and were more likely to have three-vessel disease. Importantly, the 
culprit lesion was more frequently located in the left main (LM) artery or the dominant LCx 
artery compared to patients who survived the first 30 days post-STEMI. Finally, a higher 
prevalence of a left dominant system was observed in patients who died within the first 30 
days post-STEMI (Table 2).
Multivariate logistic regression analyses demonstrated that coronary vessel dominance 
and age were independent predictors of both the primary and secondary endpoint within 
30 days post-STEMI (Table 3). A left dominant system was associated with an OR of 2.51 
(95%CI 1.11-5.67) for 30-day mortality and with an OR of 2.25 (95%CI 1.09-4.61) for 
reinfarction or cardiac death within 30 days post-STEMI.
Table 2. Differences in baseline characteristics between patients who died within the first 30 days post-
STEMI and survivors of the first 30 days post-STEMI
deceased within the first 30 
days post-sTEmI
n=45




Gender(female) 18 (40%) 263 (24%) 0.016
Age(years) 73±12 60±12 <0.001
Diabetes 7 (16%) 110 (10%) 0.194
Hypercholesterolemia 8 (19%) 183 (17%) 0.764
Hypertension 15 (35%) 346 (32%) 0.677
Current smoking 12 (29%) 537 (49%) 0.011
Killip class ≥2 during STEMI 27 (61%) 39 (4%) <0.001
Extent of Cad
One-vessel disease 12 (27%) 594 (55%) <0.001
Two-vessel disease 15 (33%) 335 (31%) 0.724
Three-vessel disease 18 (40%) 157 (15%) <0.001
Culprit vessel
LM 5 (11%) 2 (0.2%) <0.001
RCA 14 (31%) 424 (39%) 0.285
LAD 19 (42%) 493 (45%) 0.675
LCx 7 (16%) 167 (15%) 0.974
Dominant LCx 5 (11%) 31 (3%) 0.002
Coronary vessel dominance
Right dominant 35 (78%) 936 (86%) 0.113
Left dominant 9 (20%) 93 (9%) 0.009
Balanced 1 (2%) 57 (5%) 0.367
CAD=coronary artery disease; LAD=left anterior descending; LCx=left circumflex; LM=left main ; 
RCA=right coronary; STEMI=ST-segment elevation myocardial infarction.
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Coronary vessel dominance and long-term outcome in survivors of the first 
30 days post-STEMI
A total of 1086 patients survived the first 30 days post-STEMI. The primary endpoint was 
reached in 74 patients (7%) and the secondary endpoint was reached in 98 patients (9%) 
during long-term follow-up. No differences in the cumulative incidence of the primary 
endpoint were observed between patients (log-rank P=0.259; Figure 2A). Moreover, no 
differences in cumulative incidences for the secondary endpoint were observed (log-rank 
p=0.117; Figure 2B). Multivariate Cox regression analysis showed that coronary vessel 
dominance was not associated with the occurrence of either the primary or secondary 
endpoint during long-term follow-up in patients who survived the first 30 days post-STEMI 
(Table 4). Age, gender, three-vessel disease and peak cardiac troponin T levels were inde-
pendently associated with the primary endpoint of all-cause mortality in this subgroup of 
patients. Independent predictors of the secondary endpoint were gender, Killip class during 
STEMI, three-vessel disease, left ventricular ejection fraction at discharge and a reinfarction 
within the first 30 days post-STEMI (Table 4).
dIsCussIon
The main finding of this study is that a left dominant system is associated with an increased 
risk of all-cause mortality and reinfarction or cardiac death post-STEMI. Importantly, a left 
dominant system had a more than 2-fold increased risk of mortality within the first 30 
days post-STEMI, whereas in patients surviving the first 30 days post-STEMI cumulative 





reinfarction or cardiac death
or 95%CI p-value or 95%CI p-value
Age 1.10 (1.06-1.14) <0.001 1.06 (1.03-1.09) 0.001
Gender(male) 1.06 (0.52-2.17) 0.871 1.30 (0.69-2.44) 0.419
Diabetes 1.72 (0.63-4.70) 0.520 1.93 (0.96-3.88) 0.067
Hypertension 0.59 (0.26-1.32) 0.453 0.78 (0.44-1.39) 0.395
Current smoking 0.89 (0.37-2.12) 0.799 0.72 (0.39-1.33) 0.288
Coronary Vessel dominance
Right Reference(1.0) Reference(1.0)
Left 2.51 (1.11-5.67) 0.027 2.25 (1.09-4.61) 0.028
Balanced 0.73 (0.10-5.64) 0.761 1.33 (0.39-4.53) 0.650
CI=confidence interval; OR=odds ratio; STEMI=ST-segment elevation myocardial infarction.
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incidences of the primary and secondary endpoint were observed comparable to a right 
dominant or balanced system at 5 years of follow-up after STEMI.
Prognostic value of coronary vessel dominance
Currently, a left dominant system is considered to be a normal variant of the coronary 
anatomy without particular prognostic value. However, a left dominant system is less com-
mon than a right dominant system which may reflect a biological disadvantage. A study 
screening 1620 postmortem angiograms, showed that the prevalence of a left dominant 
system decreased with age15, suggesting a higher death rate among patients with a left 
figure 2. Kaplan-Meier curves for the primary and secondary endpoint in patients who survived the first 
30 days after STEMI stratified according to coronary vessel dominance.
The survivors of the first 30 days post-STEMI had similar long-term outcome showing no statistically sig-
nificant difference in cumulative incidences of all-cause mortality(A, log-rank P=0.259) or the composite 
of reinfarction and cardiac death(B, log-rank P=0.218) between patients with a right dominant, left 
dominant and balanced coronary artery system.
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dominant coronary artery system. An explanation could be that a larger amount of myo-
cardium is at risk in these patients, resulting in more extensive myocardial infarction in case 
of a left coronary artery occlusion.
Limited information is available about the prognostic value of coronary vessel dominance 
in patients with STEMI. In 27,289 patients presenting with acute coronary syndrome(ACS), 
Goldberg et al. showed that the presence of a left dominant system was associated with 
an increased mortality (HR: 1.13, 95% CI1.00-1.28).16 Accordingly, a more recent registry 
(the CathPCI registry), observed a higher in-hospital mortality after PCI in patients with a 
left dominant system (OR 1.29, 95%CI 1.17-1.42).17 However, both registries represent 
a heterogeneous patient populations, including patients with STEMI as well as non-ST-
segment elevation myocardial infarction (NSTEMI) and unstable angina, having varying 
risks.18,19 In the study by Goldberg, the increased risk of mortality in the presence of a left 
dominant system was more pronounced in patients presenting with STEMI.16 In contrast, 
in the subanalysis of the CathPCI registry the increased risk in patients with a left dominant 
system only remained significant in patients presenting with NSTEMI.17 
Our study is the first to include only patients with STEMI, demonstrating significantly 
worse outcome with a left dominant system compared to a right dominant or balanced 
system. A primary endpoint of all-cause mortality and secondary endpoint of reinfarction 
or cardiac death were studied at both short- and long-term follow-up, extending the earlier 
Table 4. Multivariate Cox regression analysis in survivors of the first 30 days post-STEMI
all-cause mortality reinfarction or cardiac death
hr 95%CI p-value hr 95%CI p-value
Age 1.05 (1.02-1.09) 0.001 0.99 (0.97-1.02) 0.727
Gender(male) 1.95 (1.02-3.70) 0.042 2.46 (1.29-4.67) 0.006
Diabetes 1.70 (0.84-3.45) 0.138 1.32 (0.70-2.51) 0.389
Hypertension 0.96 (0.56-1.63) 0.874 1.03 (0.65-1.63) 0.910
Current smoking 1.68 (0.99-2.87) 0.056 1.29 (0.82-2.01) 0.267
Killip class during STEMI 1.37 (0.96-1.95) 0.083 1.38 (0.98-1.93) 0.064
Three-vessel disease 1.93 (1.12-3.33) 0.018 2.12 (1.31-3.41) 0.002
eGFR(mL/min/1.73m2) 0.99 (0.98-1.00) 0.067 0.99 (0.99-1.00) 0.198
Peak cardiac troponin T level (μg/L) 1.06 (1.03-1.10) <0.001 1.01 (0.97-1.04) 0.637
LV ejection fraction at discharge (%) 0.97 (0.95-1.00) 0.064 0.96 (0.94-0.99) 0.002
Reinfarction within 30 days post-STEMI* 1.99 (0.58-6.82) 0.276 3.44 (1.44-8.19) 0.005
Coronary Vessel dominance
Right dominant Reference (1.00) Reference (1.00)
Left dominant 1.52 (0.73-3.19) 0.264 1.61 (0.87-2.99) 0.131
Balanced 0.93 (0.28-3.03) 0.900 1.03 (0.41-2.59) 0.944




findings.16,17 Differences in outcome compared to the CathPCI registry can be explained by 
differences in patient population and type of PCI used.
Coronary vessel dominance and 30-day outcome
In this study a more than 2-fold increased risk for 30-day mortality was found in patients 
with a left dominant system compared to a right dominant system. This can be explained 
by the impact coronary anatomy has on the extent of the infarcted area and recovery of 
left ventricular function post-STEMI. Ilia et al. showed that acute occlusion of a proximal 
dominant LCx artery resulted in a higher proportion of patients presenting with cardio-
genic shock and higher in-hospital mortality rate as compared to patients with a proximal 
LAD artery occlusion, underlining the importance of a dominant LCx artery which supplies 
approximately 60% of the left ventricular myocardium.5 Another factor contributing to the 
poor outcome of patients with a left dominant system could be lack of collateral circulation 
in patients with a left dominant system.20,21
Additionally, this study showed a higher risk of early reinfarction in patients with a left 
dominant system. Yip et al. showed that a left dominant system was independently predic-
tive of failed reperfusion in patients with LCx artery infarction.22 
Coronary vessel dominance and long-term outcome after surviving the first 
month after STEMI
Coronary vessel dominance had impact on outcome during the first 30 days post-STEMI, 
but had no prognostic significance during long-term follow-up. This could be explained 
by the fact that all patients received secondary prevention post-STEMI.14 Therefore, the 
influence of coronary vessel dominance on long-term outcome may be less prominent 
once surviving the first 30 days post-STEMI.
Limitations
This is a retrospective analysis with all inherent limitations. Second, although we adjusted 
for a wide range of potential confounders in the multivariate analysis, the possibility of 
unmeasured confounding remains. In patients who died within the first 30 days post-
STEMI, covariates such as peak cardiac troponin T level and left ventricular ejection fraction 
at discharge were incomplete or unavailable. Hence, these factors could not be corrected 
for in the multivariate analysis on 30-day outcome. Finally, hospitalization for heart failure 
has been used as clinical endpoint in patients after STEMI, but was not assessed in the 
current study.
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ConClusIons
This study demonstrated that patients with a left dominant system have worse outcome 
after STEMI, with a 2-fold increased risk of 30-day mortality and an increased risk of 
reinfarction during the first month post-STEMI. In patients surviving the first 30 days post-
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The presence of a left dominant coronary artery system is associated with worse out-
come after ST-elevation myocardial infarction (STEMI) compared with right dominance or 
a balanced coronary artery system. However, the association between coronary arterial 
dominance and left ventricular (LV) function at follow-up after STEMI is unclear. The pres-
ent study aimed at evaluating the relation between coronary arterial dominance and LV 
ejection fraction (LVEF) shortly after STEMI and at 12 months follow-up.
Methods: 
A total of 741 STEMI patients (mean age 60±11 years and 77% men) were evaluated with 
2-dimentional echocardiography within 48 hours of admission (baseline) and at 12 months 
follow-up post-STEMI. Coronary arterial dominance was assessed on the angiographic 
images obtained during primary percutaneous coronary intervention.
Results: 
A right, left and balanced dominant coronary artery system was noted in 640 (86%), 58 
(8%) and 43 (6%) patients, respectively. At baseline, significant difference in LV function 
was observed, with slightly lower LVEF in patients with a left dominant coronary artery 
system (LVEF 45 ± 8% vs. 48 ± 9% and 50 ± 9%, for left dominant, right dominant and 
balanced coronary artery system respectively, P = 0.03). However, at 12 months follow-up 
no differences in LV function or volumes were observed between the different coronary 
arterial dominance groups.
Conclusion: 
In conclusion, patients with a left dominant coronary artery system had lower LVEF early 
after STEMI. At 12 months follow-up, differences in LVEF were no longer present between 
the different coronary arterial dominance groups.
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InTroduCTIon
Left ventricular (LV) systolic dysfunction and remodeling have been strongly associated with 
short- and long-term outcomes of patients with ST-segment elevation myocardial infarc-
tion (STEMI) undergoing primary percutaneous coronary intervention (PCI).1, 2 Independent 
correlates of LV systolic dysfunction and remodeling after STEMI include infarct size, heart 
rate, and severity of coronary artery disease.3-6 The effect of coronary arterial dominance 
on LV dysfunction and remodeling at follow-up is unclear. A left dominant system, defined 
by the posterior descending artery raising from the left circumflex (LCx) artery, increases by 
approximately 13% the odds in all-cause mortality after PCI.7 To obtain more insight into 
the relation between coronary arterial dominance and LV function, the present study aimed 
at evaluating the relation between coronary arterial dominance and LV function shortly 
after the index infarction and at 12 months follow-up.
mEThods
The present study population includes patients from an original cohort of patients with 
STEMI previously published.8 From 1,131 patients with a first STEMI who were admitted at 
the Leiden University Medical Center (Leiden, The Netherlands) from 2004 to 2008, 741 
patients with completed echocardiographic examination at baseline (within 48 hours of 
admission) and at 12-months follow-up were included in the analysis (Figure 1).
The diagnosis of STEMI was defined based on criteria of typical chest pain, elevated 
cardiac enzyme levels, and typical changes on the electrocardiogram.9 All patients were 
treated according to the institutional STEMI protocol,10 which includes primary PCI and 
optimal medical therapy initiated early during hospitalization. Circulating levels of creatine 
kinase and cardiac troponin T were systematically measured every 6 hours after primary 
PCI, until the highest levels were reached. Routine 2-dimensional echocardiography was 
performed within 48 hours of admission (baseline) and repeated at 12 months follow-up. 
The association between coronary arterial dominance, assessed during admission coronary 
angiography, and changes in LV volumes and ejection fraction at 12 months follow-up was 
evaluated.
Demographic, clinical, angiographic and echocardiographic data were prospectively col-
lected in the departmental Cardiology Information System (EPD-Vision, Leiden University 
Medical Center, Leiden, the Netherlands) and retrospectively analyzed.
The digitally stored images of the coronary angiography and PCI were obtained ac-
cording to standardized angiographic projections.11 All coronary angiographic images of 
the primary PCI were retrospectively reviewed by 2 experienced observers. As previously 
described, coronary arterial dominance was defined according to the following defini-
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tion: a coronary artery system was classified as right dominant if the posterior descending 
artery (PDA) and posterolateral branch originated from the right coronary artery (RCA), left 
dominant if the PDA and the posterolateral branch originated from the LCx and balanced if 
the PDA originated from the RCA in combination with posterolateral branches originating 
from the LCx artery.12, 13 The extent of CAD was expressed as the presence of 1-, 2- or 
3-vessel disease (stenosis causing ≥50% luminal narrowing).
Images were obtained at rest with the patient in the left lateral decubitus position using 
a commercially available system (Vivid 7 and E9 [General Electric-Vingmed, Horten, Nor-
way]). Data acquisition was performed with 3.5 MHz or M5S transducers in the standard 
parasternal and apical views. M-mode, 2-dimensional, and Doppler images were acquired 
during breath hold and saved in cine-loop format. Data analysis was performed offline 
with commercially available post-processing data software, EchoPac 112.0.1 (GE Medical 
Systems, Horten, Norway).
LV function was assessed by tracing the LV end-systolic volume and end-diastolic volume 
in the apical 4- and 2-chamber views. Using the biplane Simpson’s method LV ejection 
fraction (LVEF) was calculated.14 Subsequently, the LV was divided into 16 segments to 
calculate the wall motion score index (WMSI). Every segment was individually assessed and 
scored based on its motion and systolic thickening ([1] normokinesia, [2] hypokinesia, [3] 
akinesia, [4] dyskinesia). WMSI was calculated as the sum of the segment scores divided by 

















figure 1. Patient population
Of the 1,131 patients with first STEMI of the initial patient population, 741 were finally included in the 
study population. The proportion of excluded patients and the reasons for exclusion did not significantly 
differ between different coronary arterial dominance groups (data not shown).
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The continuous variables are presented as mean ± SD or as median and interquartile 
ranges. Categorical variables are presented as number and percentages. Differences 
in baseline characteristics between the 3 coronary arterial dominance groups (right 
dominance, left dominance and balanced) were evaluated with the chi-square and 1-way 
analysis of variance tests with Bonferroni post hoc analysis for significant 1-way analysis of 
variance p values. Changes in LV volumes and LVEF from baseline to 12-month follow-up 
were evaluated using linear mixed model analyses. Subsequently, mixed-effects modeling 
approach was used to compare differences in LV volumes and LVEF among the 3 coronary 
arterial dominance groups from baseline to 12-month follow-up (group-time interaction). 
Differences within groups at baseline and at 12 months follow-up were assessed by 1-way 
analysis of variance. Statistical analysis was performed using SPSS software version 20.0 
(SPSS, Inc., Chicago, Illinois). A p value <0.05, by a 2-sided test, was considered statistically 
significant.
rEsulTs
A total of 741 patients with baseline and 12-month follow-up echocardiography were 
included. A right dominant coronary artery system was noted in 640 patients (86%), 
58 patients (8%) had a left dominant coronary artery system and 43 patients (6%) a 
balanced coronary artery system. Baseline characteristics and angiographic data of the 
patient cohort, categorized by coronary arterial dominance, are presented in Table 1. Mean 
age was 60 ± 11 years and most patients were men (n = 568, 77%). Overall, baseline 
characteristics were similar between coronary arterial dominance groups. In addition, in 
patients with a right dominant coronary artery system the RCA was more often the culprit 
vessel than in patients with a left dominant or balanced coronary artery system (P<0.01). 
On the contrary, in patients with a left dominant system, the left anterior descending (LAD) 
artery and LCx artery were more frequently affected than in patients with a right dominant 
system (P<0.01 and P=0.02 for the LAD and LCx artery, respectively). Only 10% of the 
total patient population showed 3-vessel disease. Patients with a balanced coronary artery 
system had a higher prevalence of 3-vessel disease compared with patients with a right or 
left dominant coronary artery system (21% vs. 10% and 5%, respectively, P=0.02).
Table 2 lists the comparison of LV function and volumes at baseline and 12-month 
follow-up between patients with right dominant, left dominant and balanced coronary 
artery system. At baseline, patients with a left dominant coronary artery system showed 
significantly lower LVEF compared with patients with a right dominant or balanced coronary 
artery system (LVEF 45 ± 8% vs. 48 ± 9% and 50 ± 9% for left dominant, right dominant 
and balanced coronary artery system, respectively, P = 0.03). This difference among groups 
was mainly based on the difference between patients with a left dominant and a balanced 
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coronary artery system (P = 0.025). However, at 12 months follow-up, no differences in 
LVEF or LV volumes were observed between the different coronary arterial dominance 
groups (Table 2). Similar improvement in LVEF and WMSI was noted between patients with 
a right dominant, left dominant and balanced coronary artery system (group-time interac-
tion P = 0.181 and P=0.355 for LVEF and WMSI, respectively; Figure 2). Although LV end-
systolic volume significantly decreased at 12-month follow-up in patients with a right and 
left dominant coronary artery system (Table 2), the linear mixed model analysis indicated 
that changes in LV end-systolic volume did not differ between groups (P=0.073, Figure 2C). 
In addition, the within group analysis showed that patients with a right dominant system 
had a significant increase in LV end-diastolic volume at 12-month follow-up, whereas, in 
patients with a left dominant or balanced system no change was noted (Table 2). However, 
the linear mixed model analysis showed no significant changes in LV end-diastolic volume 
over time between coronary arterial dominance groups (P = 0.106, Figure 2D).











Men 568 (77%) 494 (77%) 41 (71%) 33 (77%) 0.53
Age (years) 60 ± 11 60 ± 11 60 ± 10 59 ± 10 0.88
Diabetes mellitus 67 (9%) 55 (9%) 6 (10%) 6 (14%) 0.46
Hypercholesterolemia* 126 (17%) 108 (17%) 10 (17%) 8 (19%) 0.96
Hypertension† 224 (30%) 186 (29%) 25 (43%) 13 (30%) 0.08
Current smoker 365 (49%) 310 (48%) 31 (53%) 24 (56%) 0.52
Glomerular filtration rate (mL/min/1.73m2) 102 ± 32 102 ± 33 103 ± 31 105 ± 27 0.80
Glomerular filtration rate ≤60 mL/min/1.73m2 61 (8%) 57 (9%) 2 (3%) 2 (5%) 0.24
Peak cardiac troponin T level (μg/L) 5.8 ± 5.8 5.7 ± 5.8 5.6 ± 5.5 6.4 ± 6.3 0.77
Peak cardiac troponin T level ≥3.5 μg/L 402 (54%) 346 (54%) 30 (52%) 26 (61%) 0.66
Presenting in Killip class≥2 during STEMI 26 (4%) 21 (3%) 2 (3%) 3 (4%) 0.44
Culprit coronary artery
Left main artery 1 (0.1%) 1 (0.2%) 0 (0%) 0 (0%) 0.92
Right coronary artery 280 (38%) 268 (42%) 0 (0%) 12 (28%) <0.01
Left anterior descending artery 346 (47%) 282 (44%) 43 (74%) 21 (49%) <0.01
Left circumflex artery 114 (15%) 89 (14%) 15 (26%) 10 (23%) 0.02
no. of coronary arteries narrowed: 
1 458 (62%) 393 (61%) 42 (72%) 23 (54%) 0.52
2 210 (28%) 186 (29%) 13 (22%) 11 (26%) 0.13
3 73 (10%) 61 (10%) 3 (5%) 9 (21%) 0.02
*Serum total cholesterol ≥230 mg/dl and/or serum triglycerides ≥200 mg/dl or treatment with lipid 
lowering drugs.
†Defined as systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg and/or the 
use of antihypertensive medication.
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Left ventricular end-systolic volume (mL) 55 ± 21 59 ± 21 50 ± 21 0.10
Left ventricular end-diastolic volume (mL) 104 ± 33 107 ± 31 98 ± 31 0.35
Left ventricular ejection fraction (%) 48 ± 9 45 ± 8 50 ± 9 0.03*
Wall motion score index 1.47 ± 0.30 1.51 ± 0.28 1.48 ± 0.29 0.60
12-month follow-up echocardiography
Left ventricular end-systolic volume (mL) 51 ± 25† 51 ± 28† 51 ± 31 0.97
Left ventricular end-diastolic volume (mL) 109 ± 36† 104 ± 34 105 ± 39 0.49
Left ventricular ejection fraction (%) 54 ± 10† 53 ± 11† 54 ± 11† 0.67
Wall motion score index 1.26 ± 0.32† 1.24 ± 0.31† 1.27 ± 0.34† 0.87
* The difference between groups is based on the difference between patients with a left dominant and 
a balanced coronary artery system (P=0.025), as is shown with Bonferonni correction.
† P<0.01 for change over time: baseline vs. 12-months follow-up.
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figure 2. Change in left ventricular function and volumes over time in the 3 different coronary arterial 
dominance groups.
Similar improvement in LVEF and WMSI was noted among patients with a right dominant, left dominant 
and balanced coronary artery system (A and B). In addition, the decrease in LV end-systolic volume during 
the 12-month follow-up did not differ among groups €. Moreover, linear mixed model analysis showed no 




The present study demonstrated a significant difference in LV function shortly after STEMI 
among different coronary arterial dominance groups, with slightly lower LV ejection frac-
tion in patients with a left dominant coronary artery system. Furthermore, an overall 
improvement of LV function was observed during the first year after STEMI, independent 
of coronary arterial dominance. At 12-month follow-up after STEMI, LV function was 
comparable between the 3 coronary arterial dominance groups.
Previous literature has shown the prognostic importance of coronary arterial dominance 
with worse outcome in patients with a left dominant coronary system after PCI7, 15. In 
addition, a more recent investigation by our group showed an increase in 30-day mortality 
after STEMI in patients with a left dominant coronary artery system8.
LV function is one of the most important parameters determining long-term survival 
after acute infarction.16-18 However, the influence of coronary arterial dominance on LV 
function in patients with STEMI was unclear. The similar LVEF at 12 months among patients 
with different coronary arterial dominance is not surprising because final infarct size (as es-
timated by cardiac enzymes) was similar among the different groups, and infarct size is the 
main determinant of LVEF late after infarction.18 The difference in LVEF measured acutely 
after infarction among the coronary arterial dominance groups however, is of interest. The 
reduced LV function acutely after infarction is related to the combination of necrosis and 
stunning. Particularly, occlusion of the LAD coronary artery results in a larger area of stun-
ning as compared to RCA or LCx coronary artery occlusions.19 A left dominant coronary 
artery system may be a less well-balanced circulation than the other systems resulting in 
a larger area of myocardium at risk during acute coronary syndromes. Furthermore, in the 
present study, patients with a left dominant coronary artery system had higher frequency 
of LAD STEMI as compared with the other subgroups. This may lead to larger areas of 
stunning early after STEMI and lower LVEF compared to their counterparts.
Parikh et al also showed in a recent registry including 207,926 patients with an acute 
coronary syndrome that among patients with a left dominant system, the culprit lesion 
was more frequently observed in the LAD.15 Because the RCA is not likely to be the culprit 
in patients with STEMI with left dominance, the distribution of the culprit lesions shifts 
towards the LAD and LCx artery in these patients. The greater prevalence of LAD artery 
infarctions in patients with left dominant coronary artery system may have resulted in 
larger areas of stunning, resulting in the lower LVEF in the patients with a left dominant 
coronary system. LV dysfunction caused by stunning is (partially) reversible, and it is of 
interest to note that despite the differences in LVEF acutely after infarction, the LVEF at 12 
months post-infarction is the same in the different coronary arterial dominance groups. 
This suggests that more improvement in function occurs in the patients with a left domi-
nant coronary system.
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Several limitations should be acknowledged. The present evaluation included patients 
who had complete echocardiographic follow-up (at baseline and 12-month). Patients with 
prior myocardial infarction or revascularization and patients who experienced repeat acute 
coronary syndrome or died during follow-up were excluded. Therefore, the present study 
population may represent a relatively low-risk population. Accordingly, the influence of 
coronary arterial dominance on LV function after STEMI in patients with more severe coro-
nary artery disease and possibly more associated comorbidities remains to be determined. 
Furthermore, imaging data on precise infarct size and area of stunned myocardium, which 
can be measured with contrast-enhanced magnetic resonance imaging, were not avail-
able. This information would have been important to further explore the relation between 
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The arterial switch operation is the current treatment for transposition of the great arteries. 
Long-term outcome mainly depends on the patency of the transferred coronary arteries. 
This study assessed the presence of abnormal coronary findings and neoaortic root dilation 
late after arterial switch operation.
Methods: 
In 30 adult patients after arterial switch operation (22 men, 22 ± 3 years), computed 
tomography angiography was performed to assess the coronary anatomy and abnormal 
coronary findings, defined as significant stenosis, interarterial coronary course, and acute 
angled coronary origins. Neoaortic root dimensions and coronary takeoff height were also 
assessed.
Results: 
The most common coronary anatomy pattern was found in 24 of 30 patients. Variant 
anatomy patterns were seen in 6 patients (5 with aberrant circumflex artery, 1 with a 
single ostium). The prevalence of abnormal coronary findings was higher in patients with 
variant coronary pattern as compared with patients with common coronary pattern (100% 
and 29%, respectively; p = 0.003). In particular, an acute angle of the coronary origin 
was frequently observed. In patients with an acute angle, larger dimensions of the aortic 
annulus (p = 0.016) and the sinus of Valsalva (p = 0.002) were observed. Moreover, a 
higher takeoff of the right (p = 0.030) and left (p = 0.002) coronary ostium was noted in 
patients with acute angles.
Conclusions: 
Abnormal coronary findings were frequently observed in adult patients after arterial switch 
operation, especially in patients with a variant coronary anatomy pattern. Neoaortic root 
dilation and a higher coronary takeoff may explain part of the pathophysiology. Long-term 
follow-up is needed to determine the clinical significance of these findings.
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InTroduCTIon
Transposition of the great arteries (TGA) is a common form of cyanotic heart disease com-
prising 3% of all congenital heart defects1. Currently, the arterial switch operation (ASO) 
is the preferred surgical approach for patients with TGA2,3, with low operative mortality 
and excellent childhood survival4. However, late cardiac complications have been reported 
in children and young adults, including dilation of the neo-aortic root with subsequent 
aortic regurgitation5,6, and coronary obstructions7-10. Therefore, lifelong follow-up is rec-
ommended after ASO and a one-time evaluation of the patency of the coronary arteries 
has to be considered according to the current guidelines.2,3 An advantage of computed 
tomography coronary angiography (CTA) for the evaluation of the coronary arteries is 
the ability to visualize the course of the coronary arteries in relation to the great vessels.11 
Indeed, previous studies showed that CTA is valuable for the detection of coronary com-
plications after the ASO12-15. However, in the majority of these previous studies the studied 
patient population is relatively young with a mainly of pediatric patients. The present study 
evaluated the coronary anatomy and patency at long-term follow-up in adult patients late 
after ASO with specific attention for the relation between abnormal coronary findings, 
coronary take-off from the neo-aorta and neo-aortic root dimensions.
PaTIEnTs and mEThods 
The study population consisted of consecutive patients with TGA corrected by ASO clini-
cally referred for a one-time evaluation of the coronary anatomy by CTA2,3 in our center 
between 2008 and 2012. Clinical data were collected from the departmental Cardiology 
Information System (EPD-Vision®, Leiden University Medical Center) and all and CTA 
images were retrospectively analyzed. The Medical Ethics Committee of the Leiden Univer-
sity Medical Center approved this retrospective evaluation of clinically acquired data and 
waived the need for written informed consent.
Clinical evaluation
Peri-operative medical and surgical reports were retrospectively reviewed for the descrip-
tion of the pre-operative coronary anatomy pattern using the previously described Leiden 
classification (Figure 1)16. Furthermore, clinical follow-up data were retrieved from the 
regular visits at the out-patient clinic and were used to assess the presence of chest pain 
and New York Heart Association (NYHA) class at the time of referral for CTA. In addition, 
echocardiography was performed, calculating the left ventricular dimensions and ejection 




Computed tomography angiography: data acquisition
Patients were scanned using a 320-row CTA scanner (Aquilion ONE, Toshiba Medical 
Systems, Otawara, Japan). Patients with a heart rate exceeding 65/min received 50-100mg 
metoprolol orally 1h before data acquisition, unless contraindicated. Scan acquisition was 
performed using prospective triggering at 70-80% of the RR-interval and using a mean 
dose of 60-80mL contrast media (Iomeron400; Bracco, Milan, Italy) intravenously. The 
mean radiation dose was 3.2±1.0mSv.
figure 1. Leiden classification for the pre- and post-operative coronary anatomy pattern.
The coronary arteries arise from the facing sinuses and the non-coronary sinus is called the non-
facing(NF) sinus. The observer is positioned in the NF cusp, looking towards the pulmonary trunk(PT), 
and the sinus on his/her right hand sinus is designated “sinus 1” and the left hand sinus “sinus 2”. The 
coronary arteries are considered separately. The most common coronary artery pattern is depicted in box 
A. Box B shows the most frequently observed variant coronary artery pattern in patients with TGA, with 
an aberrant Cx artery arising from the RCA artery. A single ostium coronary anatomy, where the RCA, 
LAD and Cx artery all arise from the same sinus is depicted in box C.
Ao=Aorta ; Cx=Circumflex artery; L= left anterior descending artery; Neo-Ao=neo-aorta; NF=non-facing; 
PT=pulmonary trunk; R= right coronary artery. Direction arrows in figure: A=anterior; L=left; P=posterior; 
R=right.
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Computed tomography angiography: image analysis
Image analysis was performed by 2 experienced observers in consensus on a dedicated 
workstation (Vitrea FX 1.0, Vital Images, Minnetonka, MN, USA). The Leiden classification 
(Figure 1) was used now to describe the post-operative coronary anatomy pattern on CTA 
and the following abnormal coronary findings were noted: significant coronary stenosis 
(≥50% luminal narrowing), an inter-arterial coronary course and an acute angle of the 
coronary origin causing non-significant ostial luminal narrowing of approximately 30%. 
For measurement of the coronary angle, the angle between the neo-aortic wall and the 
midline of the proximal coronary segment was measured on the axial slices (Figure 2). 
A sharp take-off of the coronary artery was defined as an acute angle, when the angle 
measured was ≤30 degrees and this could be confirmed visually on 3D-reconstructions.
figure 2. Example of the coronary angle measurement on CTA.
Panel 2A shows an example of the measurement of a normal angle of the RCA origin(left panel, axial 
slice) as was confirmed on the three-dimensional view(right panel). Panel 2B shows an example of a 
patient with an acute angle of the Cx origin (22 degrees, left panel, axial slice), as confirmed on the 
three-dimensional view(right panel).
Ao=neo-Aorta; LAD=left anterior descending coronary artery; Cx=Circumflex coronary artery ; 
PT=pulmonary trunk; RCA=right coronary artery.
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Neo-aortic root dimensions were measured as previously described18, excluding patients 
with a previous Bentall procedure. In brief, the cross-sectional diameters were measured 
at the level of the aortic valve annulus (directly beneath the lowest insertion points of the 
aortic cusps) and at the level of the sinus of Valsalva after alignment of the axial, sagittal 
and coronal planes. The coronary take-off height was defined as the distance between the 
aortic valve annulus and the coronary ostium on coronal and sagittal planes.
Statistical analysis
Statistical analysis was performed using SPSS (version 18.0, SPSS Inc., Chicago, IL, USA). 
Continuous variables were expressed as mean ± standard deviations (SD) and categorical 
variables as numbers and percentages. Differences were tested using a 2-sided Fisher’s 
exact-test or one-way analysis of variance (ANOVA) as appropriate. For comparison pur-
poses patients were divided into 2 groups: 1) patients with the common coronary pattern 
(1R-2LCx) and 2) patients with variant coronary artery pattern. In addition, the neo-aortic 
root dimensions between patients with and without an acute angle of the coronary origin 
were compared. P value ≤ 0.05 was considered statistically significant.
rEsulTs
Patient population 
The study population comprised 30 consecutive patients (22 male, 22±3 years) referred 
for CTA after ASO. In 27 patients (90%) there was no associated congenital heart disease. 
Arterial switch operation was performed at a median age of 5 days [25–75th percentile: 
3-13 days]. During clinical follow-up (Table 1), 8 (27%) patients were re-operated: in 6 
patients a severe supravalvular pulmonary stenosis was treated and in 2 patients a Bentall 
was performed because of neo-aortic root dilation and severe aortic regurgitation. Fur-
thermore, 2 patients received an implantable cardiac defibrillator because of ventricular 
arrhythmias. At the time of referral for CTA, atypical chest pain was noted in 7 patients 
(23%), all patients were in NYHA class I or II and left ventricular ejection fraction was 
57±8%, mean left ventricular end-diastolic volume was 144±34ml and mean end-systolic 
volume 63±19ml (Table 1).
Computed tomography coronary angiography results
The pre-operative coronary anatomy reported during the ASO corresponded with the 
post-operative coronary anatomy pattern observed on CTA in all patients: 1R-2LCx in 24 
patients (80%), 1CxR-2L in 5 patients (17%) and 2RLCx in 1 patient (3%). The latter 2 
patterns were designated as variant coronary anatomy pattern and 1R-2LCx as common 
coronary anatomy pattern.
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Table 1. Patient characteristics – at time of CTA
Total
n=30
Gender (male) 22 (73%)
age (years) [range] 22±3 [18-28]
Clinical characteristics
BMI (kg/m2) [range] 23±3 [17-32]





Family history of premature CAD† 7 (23%)
Smoking 4 (13%)
Cardiac clinical history
Patients requiring re-operation during follow-up 8 (27%)
Correction of supravalvular pulmonary stenosis 6 (20%)
Aortic valve and ascending aorta replacement 2 (7%)
Other severe adverse cardiac events
Peri-operative myocardial infarction 1 (3%)





Chest pain (atypical) 7 (23%)
nyha function Class
NYHA class I 24 (80%)
NYHA class II 6 (20%)
NYHA class III or IV 0 (0%)
Echocardiography
LV-EF (%) 57±8
LV-EDV (mL) [range] 144±34 [97-220]
LV-ESV (mL) [range] 63±19 [39-110]
*Defined as systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg and/or the 
use of antihypertensive medication. †Defined as presence of coronary artery disease in first degree family 
members at <55 years in men and <65 years in women.
ACE-inhibitor=angiotensin-converting-enzyme inhibitor; BMI=body mass index; CAD=coronary artery 
disease; EDV= end diastolic volume; EF=ejection fraction; ESV= end systolic volume; ICD=Implantable 
Cardioverter Defibrillator; NYHA=New York heart association; LV=left ventricle.
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Abnormal coronary findings were observed in 13 patients (43%). In particular, 1 patient 
had significant coronary luminal narrowing in the proximal LAD (Figure 3A). The CTA of this 
patient showed that the stenosis was due to a fibrotic lesion rather than to atherosclerotic 
plaque formation. Conventional coronary angiography confirmed the significant stenosis 
and subsequently stent implantation was performed. An inter-arterial coronary course was 
observed in 5 patients (17%), including 1 patient with a single ostium coronary anatomy, in 
whom the inter-arterial course was also present pre-operatively (Figure 3B: Case example). 
Inherent to the course of the coronary arteries when running between the neo-aorta and 
the pulmonary artery, the coronaries had an acute angle of the coronary origin in all 5 
patients with an inter-arterial course. An acute angle of the coronary origin, as solitary 
abnormal coronary finding, was noted in 7 patients (23%) (Figure 3C: Case example). 
Notably, in 4 out of 7 patients with an acute angle both the left and the right coronary 
ostia were affected. There was no significant association between the presence of chest 
pain symptoms and the abnormal coronary findings (P=0.427).
The mean diameter of the aortic valve annulus was 27±3mm and the mean diameter 
of the sinus of Valsalva was 38±4mm (Table 2). Both diameters were relatively large as 
compared to normal values19. The take-off height of the right and left coronary ostia 
was 28±5mm and 26±6mm, respectively, exceeding the normal values of 15±3mm and 
20±3mm for the right and left coronary ostium, respectively (Table 2).
Computed tomography findings in common versus variant coronary 
anatomy pattern
The observed abnormal coronary findings on CTA were noted in 7/24 patients (29%) with 
a common post-operative coronary anatomy pattern and in all 6 patients (100%) with a 
variant coronary anatomy pattern (P=0.003, Table 3). In addition, a high occurrence of 
an acute angle of the coronary origin was noted, with a higher prevalence in patients 
with variant coronary anatomy (13% vs. 67% for common and variant coronary pattern, 
respectively, P=0.016). Furthermore, the take-off of the left coronary ostium was higher 
in patients with variant coronary pattern (24±5 vs. 31±6mm for common and variant 
anatomy, respectively, P=0.016). No differences in the aortic root dimensions were ob-
served between patients with common and variant coronary pattern.
Table 2. Neo-aortic root dimensions on CTA in patients after ASO and normal references values.
Patients after aso (n=28)* normal references†
Aortic Annulus (mm) [range] 27±3 [22-33] 23±3 [16-30]
Sinus of Valsalva (mm) [range] 38±4 [29-47] 34±4 [26-44]
Right coronary ostium height (mm) [range] 28±5 [16-37] 15±3 [8-26]
Left coronary ostium height (mm) [range] 26±6 [16-39] 20±3 [13-28]
*Two patients with previous Bentall-procedure in the cardiac history were excluded from this analysis. 
†Normal references are adapted from the control population in the study of Stolzmann et al.[19].





figure 3. Case examples of patients with abnormal coronary findings on CTA.
a. A significant proximal LAD stenosis caused by fibrocellular intimal thickening. The stenosis is located 
close to the ostium(arrow) and a post-stenotic dilation can be observed. Axial slice(Left panel); multi-
planar reconstruction of the LAD artery(right panel).
b. Inter-arterial course of the RCA, coursing between the neo-aorta and the pulmonary artery(arrow: 
left panel), as is also visible on the sagittal axis image(white circle: right panel).
C. Acute angle of the LAD artery(white arrows), possibly causing coronary ostium compression. Axial 
slice(Left panel); 3D-reconstruction(right panel).
Ao=neo-Aorta ; LA=left atrium; LAD=left anterior descending coronary artery; LV=left ventricle; 
PT=pulmonary trunk; RCA=right coronary artery; RV=right ventricle.
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Acute angle versus neo-aortic root dimensions
In the patients with an acute angle of the coronary origin the diameters of the aortic valve 
annulus and the sinus of Valsalva were significantly larger than in patients without an acute 
angle (P=0.016 and P=0.002 respectively, Table 4). In addition, higher coronary take-off 
was observed in patients with an acute angle as compared to patients without an acute 
angle (P=0.030 and P=0.002 for the right and left coronary artery, respectively, Table 4).
CommEnT
The current study evaluated the coronary anatomy in adult patients with a TGA corrected 
by ASO. The main observations were: 1) a high prevalence of abnormal coronary findings, 
2) a higher occurrence of these coronary abnormalities in patients with a variant coronary 
anatomy pattern, and 3) larger neo-aortic root dimensions and higher coronary take-off in 
patients with an acute angle of the coronary origin. These observations may partly explain 
the pathophysiology of coronary ostial lesions in patients after ASO.











Patients with abnormal CTa 13 (43%) 7 (29%) 6 (100%) 0.003
Significant coronary stenosis (>50%) 1 (3%) 0 (0%) 1 (17%) 0.200
Inter-arterial coronary course 5 (17%) 4 (17%) 1 (17%) 0.746
Acute angled coronary origin 7 (23%) 3 (13%) 4 (67%) 0.016
height of the coronary ostia (mm)*
Right coronary ostium [range] 28±5 [16-37] 27±5 [16-35] 30±6 [20-37] 0.306
Left coronary ostium [range] 26±6 [16-39] 25±5 [16-38] 31±6 [22-39] 0.021
*Two patients with previous Bentall-procedure in the cardiac history were excluded from this analysis.
Table 4. Neo-aortic root dimensions and coronary ostial height in patients with and without an acute 






Aortic Annulus (mm) [range] 27±3 [22-33] 30±2 [28-33] 0.016
Sinus of Valsalva (mm) [range] 36±4 [29-43] 42±3 [39-47] 0.002
Right coronary ostium height (mm) [range] 26±5 [16-32] 31±5 [24-37] 0.030
Left coronary ostium height (mm) [range] 24±5 [16-31] 32±6 [25-39] 0.002
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Coronary artery anatomy pattern and the occurrence of coronary 
obstructions
In patients with TGA a large variability in coronary anatomy is encountered and the pre-
operative coronary anatomy pattern is known to influence the prognosis of patients after 
ASO5-8. A high prevalence of coronary stenosis has been reported after ASO, ranging from 
7% to 12%, even in asymptomatic patients.5,20 In our study a significant coronary stenosis 
of the proximal LAD with post-stenotic dilation was found in 1 patient. Of interest, this pa-
tient did not experience chest pain and had excellent exercise capacity. Lack of symptoms 
in patients after ASO could be attributable to per-operative sympathetic denervation21. 
Furthermore, an inter-arterial course was observed in 5 patients. Three of these patients 
underwent subsequent myocardial perfusion SPECT, showing persistent perfusion defects, 
but no signs of ischemia. Perfusion defects on myocardial scintigraphy in patients after ASO 
are usually related to the insult of open heart surgery rather than to coronary artery lesions, 
hampering the interpretation of myocardial scintigraphy results in patients after ASO22. An 
inter-arterial coronary course is often seen in coronary arteries where the coronary artery 
origin is located close to the commissure23, as was observed in this study in the patient with 
the single ostium. Furthermore, post-operative inter-arterial coronary course could reflect 
technical problems during the operation, such as insufficient length of the coronary artery 
to allow coronary transfer to a more lateral position by the surgeon24. On the other hand, 
the inter-arterial course may become more pronounced in adult patients due to growth of 
the neo-aorta.
Furthermore, variations in coronary artery branching patterns are associated with 
complicated coronary transfer9,10. The most frequently observed variant coronary anatomy 
pattern, with an aberrant Cx artery arising from the RCA artery (1CxR-2L), was observed in 
17% of our patient population. In the study by Ou et al.12 all Cx lesions occurred in patients 
with this variant coronary pattern. Our study showed a higher occurrence of an acute 
angled coronary origin in patients with this variant coronary pattern. These observations 
may be related to a more challenging coronary transfer in patients with this pattern, where 
the long initially retro-aortic Cx artery is possibly stretched by its new positioning behind 
the neo-aorta. Yet, the occurrence of an acute angle may also relate to the neo-aortic 
growth during follow-up.
Coronary take-off in relation with the neo-aortic root dimensions 
A frequently observed complication after ASO is neo-aortic root dilation9,23. A possible 
explanation for neo-aortic root dilation could be the structural vascular differences of the 
aorta and pulmonary artery in patients with TGA24. In this study, 2 patients underwent a 
Bentall procedure for severe neo-aortic root dilation. In the remaining 28 patients, slightly 
enlarged aortic root dimensions were observed, with even larger dimensions in patients 
with an acute angle of the coronary origin. Based on these observations, we hypothesize 
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that dilation of the neo-aortic root could contribute to the development of an acute angle 
of the coronary origin during follow-up after ASO.
Not surprisingly, the height of take-off of the coronary ostia was larger in our patients as 
compared to healthy subjects19, related to the technique of ASO where the coronary ostia 
are always implanted at a higher level than their natural level to avoid coronary kinking. In 
our center, whenever feasible, the coronary arteries were re-implanted as buttons, keeping 
the coronary ostial height limited compared to when a trap-door technique is used25. In 
patients with an acute angle of the coronary ostial height was larger, possibly explaining 
part of the pathophysiology of this coronary abnormality.
Limitations and strengths 
The current study has several limitations. First, this is a retrospective study of prospectively 
gathered data. However, all patients were clinically referred for CTA, regardless of the 
presence of chest pain symptoms and CTA was performed using the same protocol, mak-
ing a reliable comparison feasible. Secondly, the present patient population is relatively 
small. Still, data on coronary anatomy in adult patients after ASO are scarce and as only 
adult patients after ASO were included in the current study, the mean ages of this patient 
population was relatively high. Thirdly, although these angled origins may be potential 
risk locations for the development of future ostial coronary lesions causing limitations in 
coronary blood flow ,the clinical significance of the described abnormal coronary find-
ings, mainly the presence of an acute angle of the coronary origin, remains uncertain. 
Importantly, to our best knowledge this is the first study proposing a pathophysiological 
relation between the observed coronary anatomy and the neo-aorta root dimensions in 
adult patients late after ASO.
ConClusIons and ClInICal ImPlICaTIons
The present study provided detailed information on the coronary anatomy late after the 
ASO and showed that abnormal coronary findings on CTA are often encountered in adult 
patients after ASO. Abnormal coronary findings were more frequently observed in patients 
with a variant coronary anatomy pattern, with a higher occurrence of an acute angle of the 
coronary origin. Significantly larger neo-aortic root dimensions and higher coronary artery 
take-off were observed in patients with acute angled coronary origins. Accordingly, these 
findings could be predictors for the development of an acute angle of the coronary origin 
during follow-up. The current observations may help explaining the pathophysiology of the 
ostial coronary lesions that are frequently encountered in patients after ASO. Although the 
clinical significance of these findings remains uncertain until longer-term follow-up is avail-
able, we feel that the lack of symptoms and the potential life-threatening consequences 
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of coronary flow obstruction may justify repeated imaging, especially in patients with a 
variant coronary anatomy and/or neo-aortic root dilation since these patients seem to be 
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Despite its high prognostic value, widespread clinical implementation of 123I-meta-
iodobenzylguanidine (MIBG) myocardial scintigraphy is hampered by a lack of validation 
and standardization. The purpose of this study was to assess the reliability of planar MIBG 
myocardial scintigraphy in patients with heart failure (HF).
Methods: 
Planar myocardial MIBG images of 70 HF patients were analyzed by two experienced and 
one inexperienced observer. The reproducibility of early and delayed heart-to-mediastinum 
(H/M) ratios, as well as washout rate (WR) calculated by two different methods, was as-
sessed using the intraclass correlation coefficient (ICC) and the Bland-Altman analysis. 
In addition, a subanalysis in patients with a very low H/M ratio (delayed H/M ratio <1.4) 
was performed. The delayed H/M ratio was also assessed using fixed-size oval and circular 
cardiac regions of interest (ROI).
Results: 
Intra- and interobserver analyses and experienced versus inexperienced observer analysis 
showed excellent agreement for the measured early and delayed H/M ratios and WR on 
planar 123I-MIBG images (the ICCs for the delayed H/M ratios were 0.98, 0.96 and 0.90, 
respectively). In addition, the WR without background correction resulted in higher reli-
ability than the WR with background correction (the interobserver Bland-Altman 95 % 
limits of agreement were -2.50 to 2.16 and -10.10 to 10.14, respectively). Furthermore, 
the delayed H/M ratio measurements remained reliable in a subgroup of patients with a 
very low delayed H/M ratio (ICC 0.93 for the inter-observer analysis). Moreover, a fixed-size 
cardiac ROI could be used for the assessment of delayed H/M ratios, with good reliability 
of the measurement.
Conclusion: 
The present study showed a high reliability of planar MIBG myocardial scintigraphy in HF 
patients, confirming that MIBG myocardial scintigraphy can be implemented easily for 
clinical risk stratification in HF.
Reproducibility of planar 123I-MIBG myocardial scintigraphy
97
InTroduCTIon 
The aging of the population and the improved medical treatment of cardiac patients has 
led to an increased prevalence of heart failure (HF)1. Despite the therapeutic innovations, 
the mortality rate of patients with HF remains high with an estimated 5-year mortality rate 
of 54% in men and 40% in women2.
Increased myocardial sympathetic activity is a prominent feature of HF by which the 
failing heart tries to compensate for the reduced cardiac output3. In the chronic state of HF 
these compensatory mechanisms become deleterious, causing myocardial hypertrophy and 
fibrosis, leading to cardiac remodeling and restructuring4. On a cellular level, the increased 
sympathetic activity causes an increased neuronal release of norepinephrine (NE), leading 
to a significant reduction of pre-synaptic NE uptake due to post-transcriptional down-
regulation of the cardiac NE transporter5. The decrease in the NE reuptake mechanism 
can be assessed non-invasively by radionuclide imaging with the iodine-123-labeled NE 
analog meta-iodobenzylguanidine (MIBG)6. MIBG is taken up into the presynaptic cardiac 
sympathetic nerves by the NE uptake-1 transporter and the amount of MIBG retention 
over several hours after administration reflects neuronal integrity7. The most commonly 
used quantitative measurement of myocardial MIBG uptake is the calculated heart-to-
mediastinum (H/M) ratio and washout ratio determined from the planar MIBG images. A 
low H/M ratio is shown to be an independent predictor of ventricular tachyarrhythmia’s8,9, 
appropriate ICD-therapy10 and sudden cardiac death11 in HF patients. Moreover, reduced 
myocardial MIBG uptake has been demonstrated to have strong prognostic value12-14.
Despite the proved prognostic value of MIBG imaging in patients with HF, there are 
still several limitations which prevent this technique from being implemented as a clinical 
management tool in patients with HF15. Although almost all reports include the H/M ratio 
as the measure of myocardial uptake, the methods used to obtain this parameter show 
substantial variation16. This variation can be caused by the influence of collimator choice, 
acquisition time and duration and the location and size of the cardiac and mediastinal 
regions of interests (ROIs) on the H/M ratio17-19. Particularly in patients with HF the MIBG 
uptake can be very low, hampering the assessment of the cardiac ROI on the planar MIBG 
images. Therefore, the level of experience of drawing the cardiac ROI on the planar MIBG 
images might influence the measured H/M ratio. Moreover, because of this difficulty in 
determining the correct contours of the cardiac ROI in HF patients, the assessment of the 
location and size of the cardiac ROI might affect the measured H/M ratio more in patients 
with HF as compared to healthy subjects. Consequently, the reproducibility of MIBG imag-
ing in HF patients remains unidentified. Therefore, the purpose of this study was to assess 
the reproducibility of H/M ratio in HF patients. The study aimed to evaluate the influence 
of cardiac ROI size and position as well as the level of post-processing experience for 





Patient data and MIBG myocardial scintigraphy images collected as part of a previously de-
scribed clinical study were utilized in the present analysis10. The study population consisted 
of New York Heart Association (NYHA) functional class III–IV heart failure patients with 
impaired left ventricle ejection fraction (LVEF) ≤35% who were clinically referred for MIBG 
myocardial scintigraphy. All patients were treated according to the ACC/AHA guidelines 
for the diagnosis and management of heart failure20, receiving optimal pharmacologic 
and revascularization therapy. From the previously described patient population a random 
sample of 70 HF patients was selected for the analysis of the current study. The MIBG 
images of the selected patients were reanalyzed to evaluate the reproducibility of H/M ratio 
on the delayed planar MIBG myocardial images.
MIBG data acquisition
Patient medication that could influence MIBG myocardial uptake, predominantly antihyper-
tensive drugs and tricyclic antidepressants, were refrained. Patients were pre-treated with 
120 mg of sodium iodide to block uptake of free 123-I by the thyroid gland. Sodium iodide 
was given orally 1 h before intravenous administration of 185 MBq of MIBG (AdreView, 
General Electric, Healthcare). MIBG planar imaging was performed in supine position. A 
10-min planar image was acquired from an anterior thoracic view (256 x 256 matrix) 10 
to 15 minutes after tracer administration. Planar imaging was repeated approximately 4 h 
after tracer administration (delayed images). All camera heads were equipped with low-
energy high resolution collimators and all image acquisitions were performed with a 15% 
energy window centered at the 159keV photopeak of 123-I.
Planar MIBG image Analysis
The H/M ratio was calculated from delayed planar MIBG images using a ROI placed over 
the heart and over the upper mediastinum. Using dedicated post-processing software on 
a Syngo-MI workstation (Siemens Medical Solutions, USA), the cardiac ROI was assessed 
using a manually drawn polygonal ROI, placed over the myocardium including the left ven-
tricular cavity in the planar MIBG images (Figure 1). The mediastinal ROI with rectangular 
shape was placed in the upper half of the mediastinum and had a size of 13 x 20 pixels. The 
location of the mediastinal ROI was determined using the following anatomical landmarks: 
the lung apex as upper border, the upper cardiac border and the medial contours of the 
lungs (Figure 1). The H/M ratio was computed by dividing the average number of counts 
within the cardiac ROI by the average number of counts within the mediastinal ROI. No 
background correction was performed in this study.
Reproducibility of planar 123I-MIBG myocardial scintigraphy
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Reproducibility of H/M ratio on delayed planar MIBG imaging 
To assess the reproducibility of delayed H/M ratios, the intra- and inter-observer agree-
ments were tested. Intra-observer variability was assessed by a single reviewer (CEV) who 
reviewed all planar MIBG images twice, with at least 4 weeks between the first and the 
second review to prevent recall bias. For the inter-observer analysis two reviewers (CEV 
and MJB) independently reviewed all of planar MIBG images. Both observers (CEV and 
MJB) were experienced for the analysis of MIBG myocardial scintigraphy. Furthermore, the 
reproducibility of delayed H/M ratios between an experienced (CEV) and an inexperienced 
observer (JEM) was assessed. The inexperienced observer was given a two-hour training on 
the post-processing of MIBG images. During this training, the post-processing technique 
and the exact location of the mediastinal ROI and cardiac ROI were explained and 5 ex-
ample cases were evaluated.
Subanalysis using a manually drawn cardiac ROI versus a  
fixed size cardiac ROI
An additional analysis was performed to assess the reproducibility of the delayed H/M 
ratio using a fixed size cardiac ROI versus a manually drawn ROI. In this analysis the agree-
ment between these two measurements was tested. Two types of fixed size cardiac ROIs 
were used. First, an oval cardiac ROI was placed over the myocardium including the left 
ventricular cavity. The size of the oval ROI was 60 by 70 pixels (approximately 85 mm by 
100 mm) and the long axis of the oval was in line with the heart axis (Figure 2a). The 
second type of fixed size cardiac ROI which was tested was a circular shaped cardiac ROI. 
The circular shaped cardiac ROI had a predefined radius of 21 pixels (approximately 30 
mm) and was placed at the apex of the heart, covering a part of the myocardium and left 
ventricular cavity (Figure 2b). The mediastinal ROI was not changed in this analysis and was 
determined as previously described and depicted in Figure 1.
figure 1. Example of the mediastinal ROI and the 
manually drawn polygonal cardiac ROI on planar 
MIBG images.
The mediastinal ROI with rectangular shape (sized 
13 x 20 pixels) was placed in the upper half of 
the “anatomical landmark square” formed by 
the lung apexes (upper square border), the up-
per cardiac border (lower square border) and the 
medial contours of the lungs (medial square bor-
ders). The manually drawn polygonal cardiac ROI 





All continuous values are expressed as mean ± SD. Intra-class correlation coefficient (ICC) 
and Bland Altman analyses were used to assess the observer agreement. For clinically 
relevant agreement the following criteria were used: an ICC value of < 0.49 was con-
sidered poor, an ICC value of 0.49-0.59 was considered fair, an ICC value of 0.60-0.74 
was considered good, and an ICC value of > 0.74 was considered excellent. Sample size 
calculation was performed using the method previously described by Shoukri et al. for the 
calculation of sample size for the design of a reliability study21. The calculations were based 
on the presence of two or more observers. Furthermore, the ICC was estimated to be at 
least 0.75 with an accepted confidence interval (CI) width of the ICC of 0.20. Using these 
assumptions, we have calculated with a level of confidence of 95% that a number of 70 
patients would be sufficient to detect an ICC of 0.75 or higher with a CI of 0.20, when 
measurements are performed by two independent observers. All statistical analyses were 





figure 2. Example of oval (A) and circular fixed size (B) cardiac ROI on planar MIBG images.
The oval cardiac ROI was placed over the myocardium including the left ventricular cavity and had a size 
60 by 70 pixels (approximately 85 mm by 100 mm). The long axis of the oval was in line with the heart 
axis (A). The circular shaped cardiac ROI had a predefined radius of 21 pixels (approximately 30 mm) and 
was placed at the apex of the heart, covering a part of the myocardium and left ventricular cavity (B).
Using the oval cardiac ROI (A) the calculated H/M ratio was 1.45, compared to a H/M ratio of 1.43 when 
the circular cardiac ROI was used. In this patient the H/M ratio was 1.46 when the polygonal manually 
drawn cardiac ROI was used.




A total of 70 randomly selected patients (64.5 ± 8.7 years and 53 (76%) males) were 
included in the study. The baseline characteristics of the patient population are presented 
in Table 1. The mean New York Heart Association (NYHA) functional class was 2.6 ± 0.5, 
and the mean LVEF was 26 ± 7.4% (Table 1). The majority of 44 (63%) patients had 
ischemic cardiomyopathy. Medication consisted of angiotensin-converting enzyme inhibi-
tors or angiotensin II antagonists (89% of patients), beta-blockers (70% of patients), lipid 
lowering agents (69% of patients) and diuretics (91% of patients).
Table 1. Patient characteristics of the study population
Total 
n=70
Gender (male) 53 (76%)
age (years) 64.5 ± 8.7
heart failure characteristics
Ischemic cardiomyopathy 44 (63%)
Non-ischemic cardiomyopathy 26 (37%)
NYHA Functional Class 2.6 ± 0.5
LVEF (%) 26 ± 7.4




Family history of coronary artery diseasec 20 (29%)
Current Smoking 22 (31%)
Obesity (BMI ≥ 30 kg/m2) 22 (31%)
medication
ACE-I/ATII antagonist 62 (89%)
Beta-blocker 49 (70%)
Lipid lowering agents 48 (69%)
Diuretic 64 (91%)
Data are presented as mean values ± SD or n (%).
a Serum total cholesterol ≥230 mg/dl and/or serum triglycerides ≥200 mg/dl or treatment with lipid 
lowering drugs
b Defined as systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg and/or the 
use of antihypertensive medication
c Defined as presence of coronary artery disease in first degree family members at <55 years in men and 
<65 years in women
ACE-I: angiotensin-converting enzyme inhibitor; ATII antagonist: angiotensin II antagonists; BMI: body 
mass index; LVEF: left ventricle ejection fraction; NYHA class: New York Heart Association class.
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Reproducibility of planar MIBG imaging
The intra- and inter-observer agreements for delayed H/M ratio, as well as the agreement 
between experienced versus inexperienced observer for delayed H/M ratio are summarized 
in Table 2. The ICC for the intra-observer agreement of the delayed H/M ratio measure-
ments was 0.98 (95% CI 0.97-0.99) and for the inter-observer agreement was 0.96 (95% 
CI 0.76-0.98). The Bland-Altman analysis for the mean differences between the measure-
ments of the delayed H/M ratio showed small differences between measured delayed H/M 
ratios of the observers, with a mean difference of -0.008 ± 0.036 and -0.040 ± 0.044 for 
the intra- and inter-observer analysis, respectively (Figure 3a and 3b).
Table 2. Agreements between the measurements of the early H/M ratios, delayed H/M ratios and wash-
out rate for the intra- and inter-observer analyses
Intra-observer analysis
Early h/m ratio 
First measurement 1.56 ± 0.18
Second measurement 1.56 ± 0.18
ICC for H/M ratio (95% CI) 0.99 (0.98-0.99)
delayed h/m ratio 
First measurement 1.43 ± 0.20
Second measurement 1.44 ± 0.20
ICC for H/M ratio (95% CI) 0.98 (0.97-0.99)
washout ratio (%)
First measurement 41.5 ± 6.6
Second measurement 41.4 ± 6.4
ICC for washout ratio (95% CI) 0.99 (0.98-0.99)
Inter-observer analysis
Early h/m ratio 
First observer 1.52 ± 0.20
Second observer 1.55 ± 0.18
ICC for H/M ratio (95% CI) 0.93 (0.74-0.97)
delayed h/m ratio
First observer 1.40 ± 0.20
Second observer 1.44 ± 0.20
ICC for H/M ratio (95% CI) 0.96 (0.76-0.98)
washout ratio (%)
First observer 41.3 ± 6.0
Second observer 41.1 ± 6.5
ICC for washout ratio (95% CI) 0.95 (0.92-0.97)
Data are presented as mean values ± SD. The intra- and inter-observer analysis both showed excellent 
agreement. The experienced versus the inexperienced observer analysis showed good agreement. Data 
are presented as mean ± SD.
Abbreviations: CI: confidence interval; H/M ratio: heart to mediastinum ratio; ICC: Intra-class Correlation 
Coefficient.




c. Experienced versus inexperienced observer analysis
figure 3. Relationships and agreements of the measured delayed H/M ratio between observers.
Reproducibility of H/M ratio on delayed planar MIBG images. A. Intra-observer agreement, b. inter-
observer agreement and c. experienced versus inexperienced observer agreement. The right panels show 
the Bland-Altman plots of the difference vs. mean for the first measurement and the second measure-
ment (a) and the first and second observer (b and c). In the intra-observer analysis a Bland-Altman 
mean difference of -0.008 and 95% limits of agreement of -0.079 to 0.064 was observed (a). In the 
inter-observer analysis mean difference of -0.040 was observed in the Bland-Altman analysis with a 95% 
limits of agreement of -0.115 to 0.046 (b). In the experienced versus inexperienced observer analysis 




The experienced versus inexperienced observer analysis also showed an excellent agree-
ment of measured delayed H/M ratio with an ICC of 0.90 (95% CI 0.70-0.95). Bland-
Altman analysis showed a mean difference of 0.053 ± 0.075 (Figure 3c).
Fixed size cardiac ROI
The measured H/M ratios using the oval cardiac ROI as well as using the circular cardiac 
ROI showed excellent agreement compared to the H/M ratios measured when a manu-
ally drawn polygonal cardiac ROI was used, with ICCs of 0.95 (95% CI 0.93-0.97) and 
0.86 (95% CI 0.72-0.93), respectively (Table 3). Subsequently, the Bland-Altman analysis 
showed a mean difference of -0.002 ± 0.063 when the oval shaped cardiac ROI was 
used for the assessment of the H/M ratio (Figure 4a, left graph). When using the circular 
cardiac ROI, the Bland-Altman analysis showed a mean difference in the measured H/M 
ratio of -0.063 ± 0.12 (Figure 4b, left graph). In addition, the Bland-Altman analysis of the 
differences in measured mean counts in the cardiac ROI revealed that the mean counts 
measured in the oval cardiac ROI were in good agreement with the mean counts measured 
in the manually drawn cardiac ROI, with a 95% limits of agreement of -1.19 to 0.95 (Figure 
4a, middle graph). However, in the Blandt-Altman analysis of the differences in measured 
mean counts in the cardiac ROI using the circular cardiac ROI, lower mean average counts 
in the circular cardiac ROI were observed compared to the manually drawn cardiac ROI, 
with a 95% limits of agreement of -4.01 to 0.82 (Figure 4b, middle graph).
Table 3. Agreements between the measurements of the delayed H/M ratios for the experienced versus 
inexperienced observer analyses
Experienced versus Inexperienced observer
Early h/m ratio 
Experienced observer 1.56 ± 0.18
Inexperienced observer 1.54 ± 0.19
ICC for H/M ratio (95% CI) 0.94 (0.70-0.98)
delayed h/m ratio
Experienced observer 1.40 ± 0.20
Inexperienced observer 1.45 ± 0.19
ICC for H/M ratio (95% CI) 0.90 (0.70-0.95)
washout ratio (%)
Experienced observer 41.3 ± 6.0
Inexperienced observer 41.1 ± 6.5
ICC for washout ratio (95% CI) 0.92 (0.89-0.96)
Data are presented as mean values ± SD. The intra- and inter-observer analysis both showed excellent 
agreement. The experienced versus the inexperienced observer analysis showed good agreement. Data 
are presented as mean ± SD.
Abbreviations: CI: confidence interval; H/M ratio: heart to mediastinum ratio; ICC: Intra-class Correlation 
Coefficient.
Reproducibility of planar 123I-MIBG myocardial scintigraphy
105
dIsCussIon
The present study showed excellent reproducibility of the assessment of the delayed H/M 
ratios on planar MIBG images in HF patients. Particularly, when using a manually drawn 
polygonal cardiac ROI the highest level of agreement was observed between the measured 
H/M ratios. However, fixed size cardiac ROI’s can also be used for the assessment of the 
H/M ratios, showing high agreement between the measured H/M ratios when the tradi-
tional manually drawn cardiac ROI was used and the measured H/M ratios when the fixed 
size cardiac ROIs were used. Furthermore, excellent agreement was observed between 
the measured H/M ratios drawn by an experienced and an inexperienced observer. A 
short training on the post-processing technique was enough to accurately assess both 
the mediastinal ROI and the cardiac ROI, showing that a limited amount of experience 
in combination with basic anatomical knowledge sufficed to successfully reproduce the 
results of the experienced observer.
Table 4. Agreements between the measurements of the delayed H/M ratios for analysis of the manually 
drawn and fixed size cardiac ROI
fixed size oval cardiac roI
delayed planar mIbG measurements
Mean average counts per mm2 in cardiac ROI
Manually drawn ROI 23.52 ± 5.64
Fixed size ROI 23.60 ± 5.67
Delayed H/M ratio
Manually drawn ROI 1.43 ± 0.20
Fixed size ROI 1.44 ± 0.20
ICC for H/M ratio (95% CI) 0.95 (0.93-0.97)
fixed size circular cardiac roI
delayed planar mIbG measurements
Mean average counts per mm2 in cardiac ROI
Manually drawn ROI 23.52 ± 5.64
Fixed size ROI 22.13 ± 5.68
Delayed H/M ratio
Manually drawn ROI 1.43 ± 0.20
Fixed size ROI 1.38 ± 0.20
ICC for H/M ratio (95% CI) 0.86 (0.72-0.93)
Data are presented as mean values ± SD. In the analysis for the agreement between the manually drawn 
polygonal cardiac ROI and the fixed size cardiac ROI, the results for the oval ROI were in excellent agree-
ment and the circular ROI in good agreement with the manually drawn cardiac ROI.




Several studies have proven the excellent prognostic value of delayed H/M ratios inde-
pendent of other commonly used clinical parameters such as LVEF12-14. In addition, patients 
with low delayed H/M ratios showed to have higher risk of ventricular arrhythmias and 
sudden cardiac death8-11. Therefore, MIBG myocardial scintigraphy could assist in a more 
individualized treatment strategy for HF patients. Moreover, adrenergic cardiac activity 
changes in response to pharmacological treatment in patients with HF can be tracked 
with the use of MIBG imaging22-24. However, even though multiple studies support the 
usefulness of this technique, MIBG myocardial scintigraphy is not yet widespread clinically 
implemented. One factor hampering the clinical implementation of MIBG myocardial scin-
tigraphy is the lack of standardization of the acquisition and post-processing parameters18. 
Improved standardization of imaging protocols could contribute to increased applicability 
of MIBG imaging in HF patients16.
Although the H/M ratio obtained from planar images has been used as quantitative 
parameters for MIBG myocardial scintigraphy, H/M ratios may vary markedly according to 
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figure 4. Agreements between measured delayed H/M ratio using a manually drawn polygonal cardiac 
ROI and a fixed size cardiac ROI.
Reproducibility of H/M ratio on delayed planar MIBG images using fixed size cardiac ROIs. Blandt-Altman 
plots of the difference vs. the mean of the H/M ratio (left), the mean average cardiac counts (middle) 
and the mean average counts of the mediastinal ROI (right) using the manually drawn polygonal cardiac 
ROI and the fixed size cardiac ROI. When the oval shaped cardiac ROI is used, small differences between 
measurements were observed, with a Bland-Altman mean difference of -0.002 and a 95% limits of 
agreement of -0.12 to 0.12 (a). Using the circular shaped cardiac ROI, variation in the H/M ratio were 
larger, with a Bland-Altman mean difference of -0.063 and a 95% limits of agreement of -0.30 to 0.17 
(b, left). This larger mean difference in H/M ratio was caused by the wider spread and lower average 
counts in the cardiac ROI (b, middle).
Reproducibility of planar 123I-MIBG myocardial scintigraphy
107
recent study by Nakajima et al. showed that standardization of H/M ratios by a heart 
chest calibration phantom method is feasible among different collimator types, allowing 
practical use for multicenter comparison of H/M ratios27.
While the effect of collimator selection on H/M ratios has been studied, similar attention 
should be paid to the variation caused by differences in setting the mediastinal and cardiac 
ROI. Currently, many independent reports from centers in different continents showed that 
MIBG myocardial scintigraphy provides valuable prognostic information. However, among 
these different investigations there is no consensus on the shape, size and positioning 
of the ROIs for the heart and the mediastinum. The mediastinal ROI on planar cardiac 
123I-MIBG images reflects non-specific mediastinal tissue activity and is a good reference 
site for the qualification of the cardiac sympathetic innervation pattern, because of the 
small amount of scatter and the low sympathetic activity in the mediastinum28. Different 
sizes for the mediastinal ROI are reported, ranging from 7 x 7 pixels to 9 x 9 and 40 pixels 
with a 128 x 128 matrix and from 13 x 13 pixels to 20 x 20 and 100 pixels with a 256 
matrix29. However, mostly the use of a rectangular shaped mediastinal ROI is reported with 
unspecified size29. Since a rectangular shaped mediastinal ROI is depicted in the proposal 
for standardization by Flotats et al.16, we chose to use a rectangular mediastinal ROI with 
a size of 13 x 20 pixels (with a 256 x 256 matrix) placed in the upper part of the medias-
tinum. A standardized shape and size of the mediastinal ROI is preferable, because small 
differences in size can cause variations in the measured H/M ratio17.
Table 5. Sub-analysis in patients with low delayed H/M ratio for the intra-, inter- and experienced versus 
inexperienced observer agreements
Intra-observer analysis
delayed h/m ratio 
First measurement 1.28 ± 0.11
Second measurement 1.30 ± 0.10
ICC for H/M ratio (95% CI) 0.93 (0.85-0.96)
Inter-observer analysis
delayed h/m ratio
First observer 1.25 ± 0.11
Second observer 1.28 ± 0.11
ICC for H/M ratio (95% CI) 0.93 (0.74-0.97)
Experienced versus Inexperienced observer
delayed h/m ratio
Experienced observer 1.28 ± 0.11
Inexperienced observer 1.31 ± 0.12
ICC for H/M ratio (95% CI) 0.87 (0.73-0.94)
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In the current study a polygonal manually drawn cardiac ROI was used including the 
myocardium and the left ventricular cavity, resulting in excellent intra- and interobserver 
agreement of the obtained H/M ratios. However, a fixed size cardiac ROI may be advan-
tageous for future development of standardized and automatically traced cardiac ROIs. 
Therefore, we evaluated the reproducibility of two types of fixed size cardiac ROIs. Both the 
oval and the circular shaped fixed size cardiac ROI showed excellent correlation with the 
manually drawn cardiac ROI (ICC 0.95 and ICC 0.86, respectively). However, slightly more 
variation was observed when the circular shaped cardiac ROI was used. This variation could 
be explained by the fact that the circular ROI covers only a part of the heart. To prevent 
scatter from the lungs or liver a circular ROI with a radius of 21 pixels was chosen, fitting 
in the apex of the myocardium without covering surrounding lung or liver tissue. However, 
because in most HF patients the left ventricle is enlarged, a circular cardiac ROI with a 
radius of 21 pixels (approximately 30 mm) often covers only a small part of the myocardium 
in these patients. This might influence the accuracy of the measured H/M ratios in these 
patients. Okuda et al. used cardiac ROI with a radius of 30 mm in the development of a 
semi-automated algorithm for the calculation of the H/M ratio, showing high reproduc-
ibility (ICC 0.97 for the inter-observer analysis of the delayed H/M ratio). However, this 
study was performed in 37 patients of whom only 5 had HF. For future development of 
a semi-automated algorithm for the calculation of the H/M ratio in HF patients the use 
of a fixed oval cardiac ROI is probably more suitable, because a larger amount of the 
myocardium is covered using this method.
When routine clinical application of MIBG myocardial scintigraphy is encouraged by 
the effort to standardize the imaging procedure, knowledge about the acquired level of 
experience that is needed to evaluate the images is valuable. This study showed that the 
H/M ratios measured by an inexperienced observer were in excellent agreement with the 
H/M ratios measured by an experienced observer. A short two hour training examining 
5 example cases was enough for accurate setting of the mediastinal and cardiac ROI. 
This indicates that the data analysis and the interpretation of planar MIBG images are 
feasible. Therefore, MIBG myocardial scintigraphy could be implemented easily in the clini-
cal workup of HF patient.
Limitations
The current study has several limitations. First, the reproducibility of the washout rate was 
not evaluated. Instead, this study focused mainly on the delayed H/M ratio on planar MIBG 
images. Furthermore, we did not evaluate the influence of the size and location of the 
mediastinal ROI on the measured H/M ratio. However, the size of the mediastinal ROI was 
fixed (13 x 20 pixels) and the location was specified, causing a minimal amount of variation 
in the mediastinal ROI in the current analysis (as shown in the Blandt-Altman plot in Figure 
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4). Still, an automatic method to set the mediastinal ROI as “default” in order to correct 
any variation due to the operator is advisable.
ConClusIons
The present study showed excellent reproducibility of delayed H/M ratios in MIBG myo-
cardial scintigraphy in HF patients. Furthermore, we observed only small influence of the 
level of experience on the assessment of the delayed H/M ratios, indicating that the data 
analysis and interpretation of planar MIBG images is feasible. In addition, the use of a 
fixed size oval shaped cardiac ROI could make the data analysis procedure even more 
standardized. Consequently, these results could contribute to the standardization of data 
analysis and interpretation of cardiac sympathetic images. In addition, this study provides 
extra validation for accuracy of the assessment of the H/M ratio on delayed planar MIBG 
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Coronary artery disease remains one of the major health problems in 2016, with high 
morbidity and mortality numbers. Different cardiac imaging techniques can be used for 
the diagnostic and prognostic evaluation of patients with coronary artery disease. Due to 
the large number of techniques, it can be challenging for the practicing cardiologists to 
take full advantage of the different imaging modalities for the therapeutic management of 
these patients. This thesis highlights the importance of using all information provided by 
the different imaging techniques, because seemly less relevant information may assist in 
risk estimation of patients with suspected or known coronary artery disease. Moreover, this 
thesis demonstrated that the specific advantages of different imaging modalities can be 
of particular added value in specific patient groups, such as adult patients with congenital 
heart disease and/or heart failure.
The aim of this thesis was to improve the clinical usefulness of cardiac imaging in differ-
ent patient categories encountered in the daily cardiology practice, with the purpose of 
improving risk estimation in patients with suspected coronary artery disease, patients who 
suffered from STEMI and heart failure patients.
In the first part of this thesis (Part I), the presence of a left dominant coronary artery 
system was shown to be of prognostic importance in patients with suspected coronary 
artery disease and in patients with recent STEMI. Furthermore, the first part showed that 
there is a significant association between the risk of coronary artery stenosis and the pres-
ence of variant coronary anatomy in adult patients after correcting surgery for congenital 
heart disease.
The second part (Part II) describes how the use of cardiac 123I-MIBG imaging could be 
improved and therewith assist in heart failure care.
Part I: Importance of coronary arterial dominance in patients with 
suspected and known coronary artery disease
In the first part of this thesis, the clinical relevance of variations in coronary anatomy is 
evaluated in patients with suspected and known coronary artery disease. More specifically, 
the presence of a left dominant coronary artery system is shown to be of negative prog-
nostic influence in these patients. Moreover, the presence of a variant coronary anatomy 
in patients after correcting surgery for the transposition of the great arteries is associated 
with a higher incidence of abnormal coronary findings on CTCA.
Chapter 2 evaluates the prognostic value of coronary arterial dominance in relation to 
significant coronary artery disease in 1425 patients referred for CTCA. During a median 
follow-up period of 2 years after CTCA, patients were followed for the occurrence of 
non-fatal myocardial infarction and all-cause mortality. The presence of a left dominant 
coronary artery system was found to be an important and significant predictor for the 
occurrence of non-fatal myocardial infarction and all-cause mortality during follow-up. 
Moreover, a left dominant coronary artery system had incremental prognostic value over 
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the traditional cardiovascular risk factors and severity of coronary artery disease on CTCA. 
When evaluating a subgroup of patients with significant coronary artery disease on CTCA, 
patients with a left dominant coronary artery system had a significantly higher cumulative 
event rate of 35% at 3 years follow-up after CTCA, compared to 9.5% in patients with a 
right dominant coronary artery system (P<0.001). Therefore, taking into account coronary 
arterial dominance, next to the severity and extent coronary artery disease on CTCA, may 
improve risk assessment of patients with suspected coronary artery disease.
The aim of Chapter 3 was to assess influence of coronary arterial dominance on the 
short- and long-term outcome after STEMI. Coronary angiographic images of consecutive 
patients presenting with first STEMI were retrospectively reviewed to assess coronary arte-
rial dominance. Of the 1131 STEMI patients, 971 (86%) patients had a right dominant, 
102 (9%) a left dominant and 58 (5%) a balanced system. After 5 years of follow-up, 
the cumulative incidence of all-cause mortality was significantly higher in patients with 
a left dominant system, compared with a right dominant and balanced system (log-rank 
P=0.013). Importantly, patients with a left dominant system had a more than two-
fold increased risk of mortality within the first 30 days post-STEMI (OR of 2.51, 95% 
CI 1.11–5.67, P=0.027). In addition, a left dominant system was also associated with a 
higher risk of reinfarction and cardiac death within 30-days after STEMI (OR 2.25, 95% CI 
1.09–4.61, P=0.028). On the other hand, in patients surviving the first 30 days post-STEMI, 
coronary arterial dominance was not of influence on long-term outcome. Up till present, 
the awareness of the prognostic relevance of coronary arterial dominance seemed limited. 
This chapter provides novel information on the relation between coronary circulation and 
clinical outcome after STEMI.
While these previous two chapters showed that the presence of a left dominant coronary 
artery system was associated with worse outcome after STEMI, the association between 
coronary vessel dominance and LV function at follow-up after STEMI remained unclear. 
Chapter 4 evaluated the relationship between coronary vessel dominance and LV function 
on echocardiography shortly and at one year post-STEMI. A total of 741 STEMI patients 
were evaluated with 2D-echocardiography within 48 hours of admission and at 12 months 
follow-up post-STEMI. A right, left and balanced dominant coronary artery system was 
noted in 640 (86%), 58 (8%) and 43 (6%) patients, respectively. At baseline, patients with 
a left dominant coronary artery system had lower left ventricular ejection fraction (LVEF) 
early after STEMI compared with patients with a right dominant or balanced coronary 
artery system, with a mean LVEF of 45±8% in patients with a left dominant versus 48±9% 
and 50±9% in patients with a right dominant and balanced coronary artery system, respec-
tively (P=0.03). During the first year after STEMI, an overall improvement of LV function 
was observed, independent of coronary vessel dominance. At 12 months follow-up after 
STEMI, LV function was comparable between the three coronary vessel dominance groups.
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As the previous chapters describe the importance of coronary artery anatomy in patients 
with suspected coronary artery disease and post-STEMI patients, Chapter 5 demonstrated 
the influence of coronary artery anatomy on the prevalence of abnormal coronary find-
ings on CTCA in a specific group of adult patients with congenital heart disease. Patients 
with congenital heart disease have a higher prevalence of coronary anomalies or variant 
coronary anatomy. In Chapter 5 the coronary anatomy in adult patients with a transposi-
tion of the great arteries corrected by arterial switch operation was evaluated. In 30 adult 
patients, late after arterial switch operation (22 men, 22 ± 3 years), CTCA was performed 
to assess variations in coronary anatomy patterns and the presence of abnormal coro-
nary findings on CTCA. Abnormal coronary findings were defined as the presence of a 
significant coronary artery stenosis, an interarterial coronary course, and an acute angled 
coronary origin. Additionally, neo-aortic root dimensions and coronary takeoff height were 
also assessed. A variant anatomy patterns was observed in 20% of patients (6/30). All 
patients with variant coronary pattern showed to have abnormal coronary findings on 
CTCA. Therewith the prevalence of abnormal coronary findings was significantly higher in 
these patients as compared with patients with common coronary pattern (100% and 29%, 
respectively; p=0.003). In particular, an acute angle of the coronary origin was frequently 
observed. Patients with an acutely angled coronary origin showed to have significantly 
larger neoaortic root dimensions and a higher coronary artery takeoff. The observations 
presented in this study may help explain the pathophysiology of the ostial coronary lesions 
that are frequently encountered in patients after arterial switch operation.
Part II: Use of cardiac 123-iodine metaiodobenzylguanide imaging in 
patients with chronic heart failure (PART II)
In Part II of this thesis the clinical usefulness of cardiac sympathetic nerve imaging with 
cardiac 123I-MIBG imaging for the clinical management of heart failure patients is evalu-
ated. Despite the proven prognostic value of 123I-MIBG myocardial scintigraphy in patients 
with heart failure, there are still several limitations that prevent this technique from being 
implemented as a clinical management tool in patients with heart failure. The lack of vali-
dation and standardization of cardiac 123I-MIBG imaging was one of the factors hampering 
clinical implementation. Therefore, Chapter 6 investigates the reproducibility of planar 
MIBG imaging in patients with heart failure. Planar myocardial MIBG images of 70 heart 
failure patients were analyzed by two experienced and one inexperienced observer. The 
impact of the level of post-processing experience on the reproducibility of planar MIBG 
images was investigated, as well as the effect of cardiac ROI size and position on the as-
sessment of the H/M ratio. Moreover, the influence on the reproducibility of two different 
methods to assess the WR was evaluated. In addition, because of the known difficulty of 
accurate assessment of the cardiac ROI in patients with very low H/M ratios (delayed H/M 
ratio <1.4), a subanalysis was performed in these patients. The intra- and interobserver 
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analyses, as well as the experienced versus inexperienced observer analysis showed excel-
lent agreement for the measured early and delayed H/M ratios and WR on planar MIBG 
images. Furthermore, we found that a fixed size cardiac ROI could be used for the assess-
ment of delayed H/M ratios, with good reliability of the measurement. In addition, for 
the calculation of the WR, the method without background correction resulted in higher 
reliability than calculation of the WR with background correction. Finally, the delayed H/M 
ratio measurements remained reliable in a subgroup of patients with a very low delayed 
H/M ratio. In conclusion this chapter showed excellent reproducibility of cardiac 123I-MIBG 
imaging in heart failure patients, confirming this technique could easily be implemented in 
daily cardiology practice.
ConClusIons 
Over the last decade, there has been an exponential development in cardiac imaging tech-
nology. Currently, cardiac imaging plays a central role in clinical management and decision 
making in the diverse and growing population of patients encountered in daily cardiology 
practice. Important outcome-related parameters can be derived from these techniques, 
allowing better risk stratification of patients with ischemic heart disease. Still, the large 
amount of information provided by the different imaging modalities can be overwhelming 
and it can be challenging for the cardiologist to make optimal use of all information that is 
provided by the different modalities. The purpose of this thesis was to optimize the clinical 
usefulness of specific cardiac imaging modalities for particular patient categories, with the 
purpose of improving risk estimation in patients with suspected coronary artery disease, 
patients who suffered from STEMI and heart failure patients.
Part I of this thesis shows that information about coronary artery anatomy on CTCA 
or conventional angiography holds important prognostic information, predominantly in 
patients with suspected or known coronary artery disease. Several studies presented in this 
thesis showed that the presence of a left dominant coronary artery system was associated 
with worse outcome during follow-up, as compared to patients with a right dominant 
or balanced coronary artery system. In patients with suspected coronary artery disease 
referred for CTCA a higher incidence of all-cause mortality and myocardial infarction was 
observed in patients with a left dominant coronary artery system. Moreover, when those 
patients develop a ST-elevation myocardial infarction, the risk of early death and refarction 
after first STEMI seems to be increased. This thesis showed that first STEMI patients with 
a left dominant system had a more than two-fold increased risk of mortality within the 
first 30 days post-STEMI. Furthermore, this thesis demonstrated that patients with a left 
dominant coronary artery system had lower LVEF on echocardiography early after STEMI. 
On the other hand, long-term outcome post-STEMI was not influenced by coronary arte-
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rial dominance and after one year post-STEMI left ventricular function was comparable 
between the three coronary arterial dominance groups. Up till present, the value of this 
anatomical information may have been underestimated. There are multiple ‘risk models’ 
available estimating the future risk for adverse events in patients after STEMI, with the pur-
pose of optimizing secondary prevention. In these risk models known risk factors, such as 
age, gender, blood pressure and heart rate are incorporated. However, coronary anatomy 
is not taken into account in these risk scores. The incorporation of coronary anatomy in 
clinical risk scores would possibly improve the risk stratification in post-STEMI patients. 
Still, future prognostic analyses in patients with STEMI are necessary to give an answer to 
this question.
Secondly, the first part of this thesis showed that information about coronary artery 
anatomy on CTCA can be of particular added value in a specific group of adult patients with 
congenital heart disease. Because CTCA has the advantage of three-dimensional imaging 
of the coronary artery tree in relation to the great vessels, it allows better visualization of 
the coronary ostia. This thesis showed that in patient with a transposition of the great 
arteries corrected by arterial switch operation the presence of a variant coronary artery 
anatomy pattern is relatively frequently observed. Patients with a variant pattern showed 
to have a higher incidence of potential harmful abnormal coronary findings on CTCA, 
such as an acute angle of the coronary origin. Additionally, the presence of an acutely 
angled coronary origin was associated with larger neo-aortic root dimensions in these 
patients, possibly explaining part of the pathophysiology of the frequently encountered 
ostial coronary artery lesions in patients late after arterial switch operation.
Finally, Part II of this thesis demonstrated the usefulness of 123I-MIBG myocardial scintigra-
phy in patients with heart failure. Despite the large number of studies on cardiac 123I-MIBG 
imaging, methodological and analytical limitations hampered large scale implementation 
of this technique in daily cardiology practice. This thesis showed that cardiac 123I-MIBG 
imaging has excellent reproducibility and the evaluation of the planar MIBG images is 
easily performed. In addition, when using the right calculations for the assessment of the 
WR and proper cardiac ROI shape and position for the assessment of the H/M ratio, the 
image analysis can become more standardized. These data represent an important step to 
improved utility of cardiac 123I-MIBG imaging in clinical cardiology practice.
Finally, this thesis demonstrated that making optimal use of different cardiac imaging 
modalities in specific patient categories, by using all information that is provided, allows 






Ondanks de verbeteringen in de behandeling van patiënten met hart- en vaatziekten in 
de afgelopen decennia, blijven hart- en vaatziekten een belangrijk gezondheidsprobleem 
vormen in de Westerse wereld, met een hoge mortaliteit en morbiditeit. Binnen de groep 
van hart- en vaatziekten is coronairlijden leidend tot een acuut myocardinfarct, de grootste 
veroorzaker van overlijden, waarbij het verantwoordelijk is voor ongeveer 12% van al het 
overlijden wereldwijd.
De patiëntpopulatie die we tegenkomen in de cardiologiepraktijk is in de loop der jaren 
veranderd. Niet alleen het aantal patiënten met coronairlijden neemt toe, maar vanwege 
de verbeterde behandeling van een acuut hartinfarct en daarmee verbeterde overleving, is 
het aantal patiënten met ischemisch hartfalen toegenomen. Bovendien hebben er binnen 
de cardiothoracale chirurgie veel ontwikkelingen plaatsgevonden, waardoor het aantal 
volwassen patiënten met congenitale hartziekten tevens toegenomen is.
Het stellen van de juiste diagnose, evenals een goede evaluatie van de cardiale functie, is 
cruciaal voor het starten van de goede behandeling. Daarom is er de afgelopen jaren veel 
geïnvesteerd in de ontwikkeling van cardiale beeldvorming om de groeiende patiëntpopu-
latie beter in kaart te brengen. Als gevolg daarvan is er nu een groot aantal verschillende 
beeldvormingstechnieken beschikbaar in de dagelijkse cardiologiepraktijk. Aan de hand 
van de verkregen informatie wordt er vaak een verdeling gemaakt in twee groepen: anato-
mische en functionele beeldvorming. Anatomische beeldvorming focust zich voornamelijk 
op de visualisatie van de coronairen, atherosclerotische plaques en myocard structuur. 
Functionele beeldvorming richt zich onder andere op myocard perfusie, de contractiliteit 
van de hartspier en het in beeld brengen van de sympathische innervatie van het myocard.
Computed tomografie (CT) coronair angiografie is een belangrijk voorbeeld van anato-
mische beeldvorming, waarbij atherosclerose vorming en vernauwingen in de coronairen 
op een gedetailleerde en niet-invasie manier weergegeven kunnen worden. Bovendien 
verstrekt CT coronair angiografie naast deze informatie ook een duidelijk beeld van de 
coronair anatomie in relatie tot de grote vaten en de coronaire dominantie.
Coronaire dominantie wordt bepaald door de coronair arterie van waaruit de posterior 
descenderende arterie (PDA), of posterior interventriculaire arterie ontspringt. In ongeveer 
88% van de gevallen is dit de rechter coronair arterie (RCA) en is er dus sprake van een 
rechts dominante coronaire circulatie. Een links dominant coronair systeem, waarbij de 
PDA vanuit de linker circumflex arterie (LCx) ontspringt, komt minder vaak voor, met een 
prevalentie van ongeveer 7-10%. Als de PDA vanuit de RCA ontspringt, maar de grote pos-
terolaterale zijtakken vanuit de LCx ontspringen, dan noemen we de coronaire circulatie 
gebalanceerd. Een gebalanceerde circulatie wordt ongeveer in 4% van de gevallen gezien.
Coronaire dominantie beïnvloedt de relatieve contributie van de verschillende coronair 
arteriën aan de totale bloedtoevoer naar de linker ventrikel. Met andere woorden, een 
vernauwing in de coronair kan in één patiënt een groter deel van het myocard in gevaar 
brengen dan in de andere patiënt, afhankelijk van de coronair anatomie.
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De prognostische waarde van deze normale variatie in de coronair anatomie wordt in 
dit proefschrift onderzocht (deel I). De beeldvorming die gebruikt is voor de evaluatie van 
de coronair anatomie is CT coronair angiografie en conventionele percutane coronair an-
giografie in patiënten met bekend coronairlijden of de verdenking daarop, en in patiënten 
met een ST-elevatie myocardinfarct (STEMI). Tevens wordt in deel I de coronair anatomie 
geëvalueerd in volwassen patiënten met een congenitale hartaandoening. Meer specifiek 
hebben we gekeken naar patiënten met een transpositie van de grote vaten, die op zeer 
jonge leeftijd gecorrigeerd werd door middel van een arteriële switch operatie. Tijdens 
deze operatie worden de grote vaten, de aorta en de pulmonaal arterie, doorgenomen en 
in de juiste positie teruggeplaatst. De volgende zeer cruciale stap tijdens de operatie is het 
terugplaatsen, of herimplanteren van de coronairen in de nieuw gecreëerde aorta, ofwel 
‘neo-aorta’. De ‘herimplantatie’ van de coronairen kan op langere termijn problemen ge-
ven, zeker wanneer er een variatie in de coronair anatomie aanwezig is bij deze patiënten. 
De relatie tussen de aanwezigheid van een variatie in de coronaire anatomie en het risico 
op het krijgen van latere coronaire complicaties wordt beschreven in dit proefschrift.
Door de verbeterde overleving van patiënten na een hartinfarct en de veroudering in de 
samenleving, is de populatie patiënten met chronisch hartfalen gegroeid. Ondanks veel 
nieuwe therapeutische mogelijkheden blijft hartfalen een zeer hoge mortaliteit houden, 
met een sterfte percentage van ongeveer 50% binnen een periode van vijf jaar. De vraag 
naar een onderzoeksmethode die meer inzicht zouden kunnen geven over het risico op 
hartfalen progressie en het ontstaan van plotse hartdood bij deze patiëntengroep is hier-
door toegenomen. Een potentiele beeldvormingstechniek die meer inzicht zou kunnen 
bieden is 123-iodine metaiodobenzylguanine (123-MIBG) scintigrafie, waarbij de sympa-
thische innervatie van het myocard in beeld wordt gebracht. deel II van dit proefschrift 
geeft weer hoe het gebruik van cardiale MIBG scintigrafie kan worden geoptimaliseerd en 
daarmee zou kunnen bijdragen aan verbetering van de risico inschatting voor patiënten 
met hartfalen.
Deel I: Het belang van coronaire dominantie in patiënten met bekend of 
een verdenking op coronairlijden 
In hoofdstuk 2 wordt de prognostische waarde van coronaire dominantie in relatie tot de 
aanwezigheid van belangrijk coronairlijden geëvalueerd in 1425 patiënten die verwezen 
werden voor CT coronair angiografie. Na het ondergaan van CT coronair angiografie wer-
den de patiënten klinisch gevolgd gedurende een mediane follow-up periode van 2 jaar. 
De aanwezigheid van een links dominant coronair systeem bleek een belangrijke voorspel-
ler voor het ontstaan van een hartinfarct en overlijden gedurende de follow-up periode. 
Tevens toonde de resultaten aan dat de aanwezigheid van een links dominant coronair 
systeem van toegevoegde voorspellende waarde was, bovenop de ernst van het aange-
toonde coronairlijden en de al bekende cardiovasculaire risicofactoren. Bij de evaluatie 
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van een subgroep van patiënten met significant coronairlijden op CT coronair angiografie, 
laten de resultaten zien dat de cumulatieve incidentie voor het krijgen van toekomstig 
myocardinfarct of overlijden significant hoger is voor patiënten met een links dominant 
coronair systeem in vergelijking met patiënten met een rechts dominant systeem, met een 
cumulatieve incidentie van 35% versus 9.5% na 3 jaar follow-up, respectievelijk (P<0.001). 
Bovendien toont dit onderzoek aan dat, wanneer coronair dominantie meegenomen wordt 
bij de beoordeling van CT coronair angiografie, naast de beoordeling van de aanwezigheid 
en de ernst van een vernauwing in de coronairen, de risico inschatting bij patiënten met 
belangrijk coronairlijden kan worden verbeterd.
hoofdstuk 3 gaat hier nog verder op in en beschrijft de invloed van coronaire do-
minantie op de korte- en de lange termijn uitkomst na het doormaken van een STEMI. 
De beelden van de percutane coronair angiografie van 1131 STEMI patiënten werden 
retrospectief beoordeeld op coronaire dominantie, waarbij 971 (86%) patiënten een rechts 
dominant coronair systeem hadden, 102 (9%) patiënten en links dominant systeem en 
58 (5%) een gebalanceerd coronair systeem. Na een follow-up periode van 5 jaar was de 
mortaliteit significant hoger van patiënten met een links dominant systeem in vergelijking 
tot patiënten met een rechts dominant coronair systeem (log-rank P=0.013). Opvallend 
was dat patiënten met een links dominant coronair systeem zelfs een meer dan twee keer 
verhoogd risico hadden op overlijden binnen de eerste 30 dagen na het infarct (OR 2.51, 
95% CI 1.11-5.67, P=0.027). Daarbij bleek tevens dat patiënten met een links dominant 
coronair systeem een verhoogd risico hadden op het krijgen van een tweede hartinfarct 
binnen de eerste 30 dagen na de STEMI. Wanneer gekeken werd naar de subgroep pa-
tiënten die de eerste 30 dagen na de STEMI overleefden, bleek daarentegen dat coronaire 
dominantie niet van invloed was op de langere termijn overleving na een STEMI. Tot op 
heden was de kennis over de prognostische relevantie van coronaire dominantie beperkt. 
Dit hoofdstuk biedt nieuwe inzichten over de relatie tussen de coronaire circulatie en de 
klinische uitkomst na een STEMI.
Nadat in de studies beschreven in de voorgaande hoofdstukken duidelijk is geworden 
dat coronaire dominantie invloed heeft op de prognose, wordt in hoofdstuk 4 geëvalu-
eerd of coronaire dominantie ook van invloed is op de cardiale functie in patiënten na een 
hartinfarct. Van in totaal 741 STEMI patiënten werd de linker ventrikel functie beoordeeld 
op echocardiografie 48 uur na de ziekenhuisopname en 12 maanden na het hartinfarct. 
Een rechts dominant, links dominant en gebalanceerd coronair systeem werd gezien in 640 
(86%), 58 (8%) en 43 (6%) van de patiënten, respectievelijk. Op de baseline echocardio-
grafie, 48 uur na de STEMI, hadden patiënten met een links dominant systeem een lagere 
linker ventrikel ejectie fractie (LVEF) van 45±8%, in vergelijking met 48±9% bij patiënten 
met een rechts dominant en 50±9% bij patiënten met een gebalanceerd coronair systeem 
(P=0.03). Tijdens het eerste jaar na STEMI was er een verbetering in de LVEF te zien bij 
alle patiënten, onafhankelijk van coronaire dominantie. Na een periode van 12 maanden 
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follow-up na STEMI, was de linker ventrikel functie vergelijkbaar tussen de verschillende 
coronaire dominantie groepen. In conclusie was er een klein verschil in linker ventrikel 
functie tussen de dominantie groepen kort na het hartinfarct, welke niet meer aanwezig 
was na een jaar follow-up.
In de vorige hoofdstukken is het belang van de coronair anatomie in patiënten met 
coronairlijden beschreven. hoofdstuk 5 gaat vervolgens in op de invloed van coronair 
anatomie op het voorkomen van afwijkende bevindingen op CT coronairen bij patiënten 
met een specifieke congenitale hartaandoening. Het is bekend dat bij patiënten met een 
congenitale hartaandoening variaties in de coronair anatomie en coronair anomalieën va-
ker voorkomen. In dit hoofdstuk wordt de coronair anatomie van patiënten met een trans-
positie van de grote vaten, gecorrigeerd door een arteriële switch operatie, bestudeerd. 
Zoals eerder genoemd vindt tijdens deze operatie, die kort na de geboorte plaatsvindt, 
een herimplantatie van de coronairen in de ‘neo-aorta’ plaats. In 30 volwassen patiënten, 
laat na de arteriële switch operatie (leeftijd 22±3 jaar), werd een CT coronair angiografie 
gemaakt voor de evaluatie van de anatomie en eventuele abnormale bevindingen in de 
coronairen. Abnormale bevindingen werden gedefinieerd als: 1) de aanwezigheid van 
een significante vernauwing, 2) een inter-arterieel beloop van de coronair (een beloop 
tussen de grote vaten door) en 3) een scherpe hoek of knik in de coronair arterie bij het 
ontspringen vanuit de aorta. Bovendien werden de aorta-dimensies gemeten, gezien het 
feit dat als complicatie op latere leeftijd aortawortel dilatatie relatief vaak optreedt bij deze 
patiënten. Tenslotte werd tevens de hoogte van het ontspringen van de coronair vanuit de 
“neo-aorta” vastgesteld. Een variatie in de anatomie werd gezien in 20% van de patiënten. 
De meest voorkomende variatie was hierbij een Circumflex arterie die ontsprong vanuit 
de RCA. Alle patiënten met een variatie in de anatomie hadden abnormale bevindingen 
in de coronairen op CT coronair angiografie. Van belang was ook dat de aanwezigheid 
van abnormale bevindingen in de coronairen significant vaker werd gezien bij patiënten 
met een variatie in de coronair anatomie in vergelijking met patiënten met een normale 
coronair anatomie (100% en 29%, respectievelijk, P=0.003). In het bijzonder werd een 
scherpe hoek of knik in de coronair vaker gezien bij patiënten met een variatie van de 
coronair anatomie. Bij patiënten met een scherpe hoek of knik in de coronair werden 
significant grotere aorta-dimensies gemeten en ontsprong de coronair vanuit een hoger 
niveau vanuit de neo-aorta. De bevindingen beschreven in dit hoofdstuk kunnen voor een 
deel een verklaring vormen voor het probleem van het ontstaan van ostiale laesies in de 
coronairen, die relatief vaak gezien worden bij patiënten na een arteriële switch operatie.
Deel II: Het gebruik van 123-iodine metaiodobenzylguanine scintigrafie bij 
patiënten met chronisch hartfalen 
Het myocard wordt geïnnerveerd door het autonome zenuwstelsel, bestaande uit het 
sympathische en parasympatische systeem. Cardiale functies, zoals de contractiliteit en 
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de hartfrequentie, worden hiermee bestuurd. Het sympathische zenuwstelsel is dominant 
in de ventrikels met norepinefrine als meest belangrijke neurotransmitter. Metaiodoben-
zylguanine (MIBG) is een 123Iodine gelabeld norepinefrine analoog, welke visualisatie van 
de sympathische neuronale opname in het myocard mogelijk maakt. In patiënten met 
hartfalen is er een verminderde opname van 123I-MIBG in het myocard. Deze verminderde 
opname is goed zichtbaar op de planaire opnames van 123I-MIBG scintigrafie en wordt 
weergegeven als de hart-mediastinale (H/M) ratio. Verschillende onderzoeken hebben la-
ten zien dat deze verminderde opname, en daarmee een lagere H/M ratio, is geassocieerd 
met een slechtere prognose, waarbij er een hoger risico bestaat op progressie van hartfalen 
en plotse hartdood. Ondanks deze duidelijke prognostisch voorspellende waarde, speelt 
123I-MIBG scintigrafie nog een zeer bescheiden rol binnen de klinische cardiologie. Een 
van de redenen van de beperkte rol is het gebrek aan validatie en standaardisatie van de 
beeldvormingstechniek.
Derhalve wordt in hoofdstuk 6 de reproduceerbaarheid van 123I-MIBG scintigrafie in een 
populatie van hartfalen patiënten onderzocht. De planaire 123I-MIBG beelden van 70 hart-
falen patiënten werden geanalyseerd door twee ervaren observatoren en een observator 
met minder ervaring in het analyseren van de beelden. Op deze manier werd aangetoond 
dat de mate van ervaring in het analyseren van de beelden op de uitkomst van de H/M ratio 
weinig invloed had en de reproduceerbaarheid in alle gevallen goed was. Dit is van belang 
omdat het soms moeilijk lijkt de beelden te analyseren als er erg weinig myocardiale op-
name van 123I-MIBG is, zoals bij patiënten met zeer ernstig hartfalen. Daarom werd tevens 
een subgroep van patiënten met zeer ernstig hartfalen apart geanalyseerd, waarbij werd 
aangetoond dat zelfs in deze moeilijk te analyseren patiënten groep de metingen goed 
overeen kwamen. Tevens werd gedemonstreerd dat er bij de beeldanalyse een vaste vorm 
en grootte gebruikt kon worden voor het plaatsen van de cardiale regio, waarbij er een 
goede reproduceerbaarheid werd gezien. Als laatste werd ook de cardiale uitwas van 123I-
MIBG, de zogenaamde ‘washout ratio’ (WR), met twee verschillende methoden berekend, 
waarna de reproduceerbaarheid van de verschillende methoden werd getest. Hierbij kwam 
naar voren dat de methode waarbij de meest eenvoudige formule gebruikt werd, zonder 
achtergrond correctie, beter reproduceerbare resultaten liet zien. In conclusie, toont dit 
hoofdstuk aan dat cardiale 123I-MIBG scintigrafie een goede reproduceerbaarheid heeft 
in hartfalen patiënten en de beeldanalyse gemakkelijk uitvoerbaar is. Dit bevestigt dat 
deze beeldvormingstechniek betrouwbaar geïmplementeerd zou kunnen worden in de 
dagelijkse cardiologie praktijk.
Conclusies en toekomstperspectieven
De laatste decennia hebben er grote ontwikkelingen plaatsgevonden binnen de cardi-
ale beeldvorming. Momenteel speelt beeldvorming een belangrijke rol in de klinische 
behandeling van patiënten en besluitvorming in de dagelijkse cardiologie praktijk. Het 
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doel van dit proefschrift was het optimaliseren van de klinische bruikbaarheid van cardiale 
beeldvorming. Daarbij laten we zien dat bepaalde cardiale beeldvormingsmodaliteiten bij-
zondere voordelen hebben in specifieke patiënten groepen. De informatie over de coronair 
anatomie op CT coronair angiografie en conventionele angiografie heeft een belangrijke 
prognostische waarde, voornamelijk bij patiënten met coronairlijden. Verschillende onder-
zoeken die staan beschreven in dit proefschrift tonen aan dat een links dominant coronair 
systeem geassocieerd is met een slechtere uitkomst tijdens klinische follow-up. Bovendien 
wordt beschreven dat, wanneer patiënten met een links dominant systeem een STEMI 
doormaken, het risico op overlijden vroeg na het infarct en het risico op het krijgen van 
een tweede infarct verhoogd is.
De linker ventrikel ejectie fractie, gemeten middels echocardiografie, kort na de STEMI 
was licht verminderd bij patiënten met een links dominant systeem. Daarentegen, de 
langere termijn uitkomst van patiënten na een STEMI niet beïnvloed werd door coronaire 
dominantie en een jaar na STEMI de echocardiografie een vergelijkbare linker ventrikel-
functie laat zien.
Tot op heden werd de prognostische waarde van de coronair anatomie mogelijk onder-
schat. Er bestaan veel ‘risicomodellen’ die de prognose na een STEMI ‘berekenen’, om op 
die manier de secundaire preventie bij deze patiënten te optimaliseren. In deze risicomodel-
len worden bekende risicofactoren, zoals leeftijd, geslacht, bloeddruk, ECG veranderingen 
en hartfrequentie meegenomen. Coronair anatomie wordt echter niet meegenomen in 
de huidige risicomodellen. Wellicht kan het toevoegen van coronair anatomie aan de 
bestaande risicomodellen een betere risicostratificatie opleveren voor STEMI patiënten. Dit 
zal echter in de toekomst verder uitgezocht moeten worden.
De informatie over de coronair anatomie, zoals beoordeeld met CT coronair angiografie, 
kan ook van specifieke toegevoegde waarde zijn bij patiënten met congenitale hartziekten. 
Dit proefschrift toont aan dat bij volwassen patiënten met een transpositie van de grote 
vaten, die op jonge leeftijd gecorrigeerd is met een arteriële switch operatie, variaties in de 
coronair anatomie relatief vaak voorkomen. Daardoor is de kans op potentieel bedreigende 
abnormale bevindingen in de coronairen verhoogd, waarbij voornamelijk een scherphoe-
kige afgang van de coronair (ofwel een knik in de coronair) vaker gezien wordt. Bovendien 
is er een associatie met de breedte van de ‘neo-aorta’, die in patiënten na een arteriële 
switch operatie vaak dilateert, en het voorkomen van een dergelijke scherphoekige afgang 
van de coronair. De studie beschreven in dit proefschrift verklaart mogelijk een deel van 
de pathofysiologie van het ontstaan van ostiale laesies in de coronairen na een arteriële 
switch operatie.
Als laatste toont dit proefschrift aan dat planaire 123I-MIBG scintigrafie een goede re-
produceerbaarheid heeft en daarmee betrouwbaar is voor het meten van de H/M ratio. 
Bovendien werd aangetoond dat de analyse van de beelden gemakkelijk uitvoerbaar is. 
Deze bevindingen kunnen bijdragen aan de standaardisatie van planaire 123I-MIBG scinti-
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grafie. Dit is een stap in de goede richting, waarbij de bruikbaarheid en implementatie van 
cardiale 123I-MIBG scintigrafie in de cardiologie praktijk vergroot wordt.
In conclusie laat dit proefschrift zien dat bepaalde beeldvormingstechnieken een bij-
zonder voordeel hebben bij specifieke patiëntengroepen die we tegen komen binnen de 
dagelijkse cardiologie praktijk. Wanneer optimaal gebruik gemaakt wordt van de verkregen 
informatie door deze verschillende beeldvormingstechnieken, zou de risico inschatting en 
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De afgelopen jaren heb ik met veel plezier onderzoek gedaan op de afdeling cardiologie 
van het Leids Universitair Medisch Centrum. Ik wil graag iedereen bedanken die hierbij 
direct en indirect betrokken was. Een aantal mensen wil ik in het bijzonder noemen. 
Dr. A.J.H.A. Scholte: Beste copromotor, beste Arthur, bedankt voor je geduld tijdens onze 
samenwerking. Ondanks, of misschien juist dankzij de meningsverschillen die er soms wa-
ren is dit proefschrift tot stand gekomen en was onze samenwerking voor mij erg leerzaam. 
Dr. V. Delgado: Dear Victoria, the way you combine clinical work and research is admirable. 
Also the speed you maintain in working on new research projects is unequalled. Thank you 
for your help and constructing criticism on my manuscripts. 
Prof. dr. M.J. Schalij: Beste Martin, bedankt voor het gestelde vertrouwen in mij, toen je 
mij de kans hebt gegeven de opleiding cardiologie te beginnen. Ik kijk ernaar uit om mijn 
opleiding binnen het LUMC voort te zetten. Ik heb bewondering voor  manier waarop je 
iedereen aanspoort op de afdeling en het feit dat de kwaliteit van zorg en ‘de patiënt’ bij 
jou op de eerste plek komt. 
Prof. Dr. E.E. van der Wall: Beste Ernst, tijdens de eerste periode van mijn promotie ben je 
mij tot grote steun geweest. Bedankt voor de begeleiding bij mijn eerste onderzoekspro-
jecten in het LUMC en je hulp bij het opstarten van nieuwe projecten. 
Beste “Tuin collega’s”, het was altijd erg gezellig op het werk, tijdens borrels en con-
gressen. Gezien de hoeveelheid namen die ik zou moeten noemen, dankzij onze grote 
groep arts-onderzoekers, zeg ik: Bedankt allemaal! In het bijzonder: bedankt Mark, voor 
de begeleiding bij de start van mijn promotie. Michiel: bedankt voor de gezelligheid als 
kamergenoot! Noor, Carine en Sander: bedankt dat ik altijd even kon komen buurten in 
de kamer naast de ‘imaging-room’. Maurits, Sebastiaan, Gijs en Marieke: bedankt voor de 
onvergetelijke ‘road-trip’ door West-Amerika die we samen maakten. Daniëlle, ik zal onze 
tijd samen in de kliniek niet snel vergeten. Aukelien, ik ben blij dat je met enthousiasme 
mijn onderzoek hebt overgenomen. Ten slotte: Georgette, bedankt dat je mijn paranimf 
wilt zijn! Kort na jouw eigen promotie heb je me veel geholpen bij de afronding van dit 
proefschrift. 
Het CT-team: Jaap, Joella, Fleur, Mark, Cees, Marieke, Ibtihal, Michiel en Philippe: Bedankt 
voor de goede samenwerking en flexibiliteit binnen ons team. Prof. dr. W. Jukema en 
dr. G. de Groot: Beste Wouter en Greetje, bedankt voor de leerzame sessies tijdens het 
beoordelen van de klinische CT-scans. 
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mij. 
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scans. In het bijzonder Petra: je weet veel over MIBG en bent mij tot grote hulp geweest. 
Lieve broer en zus, Joris en Roosje, ik ben blij met de goede band die we als broer en 
zussen met elkaar hebben. Ik weet dat jullie er altijd voor mij zijn. Jullie onvoorwaardelijke 
steun betekent veel voor mij. Joris, zoals ik tijdens jouw verdediging van je proefschrift 
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De auteur van dit proefschrift werd geboren op 23 juni 1984, te Leiden. In 2002 behaalde 
zij haar eindexamen aan het Stedelijk Dalton Lyceum, te Dordrecht. In hetzelfde jaar startte 
zij haar studie geneeskunde aan Erasmus Universiteit Rotterdam (EUR). Naast haar studie 
nam zij vanaf 2003 deel aan het Master of Science Program voor excellente studenten, 
gecoördineerd door het Netherlands Institute of Health Sciences (NIHES). In het kader 
hiervan verrichtte zij onder andere anderhalf jaar klinisch wetenschappelijk onderzoek op 
de afdeling cardiologie in het Erasmus Medisch Centrum, naar het lange termijn effect van 
stamceltherapie in patiënten die een hartinfarct hadden doorgemaakt. Dit resulteerde in 
het behalen van de titel Master of Science in Clinical Research in 2007. Na het behalen 
van haar artsexamen in april 2009 deed zij onderzoek op de afdeling epidemiologie aan 
de EUR, waarna zij in januari 2010 de overstap maakte naar de afdeling cardiologie in 
het Leids Universitair Medisch Centrum (LUMC). Daar begon zij aan de klinische opleiding 
cardiologie, die zij van juli 2010 tot juli 2013 onderbrak voor haar promotieonderzoek on-
der leiding van Prof. dr. J.J. Bax. Het onderzoek op het gebied van cardiale beeldvorming, 
ondersteund door het Interuniversitair Cardiologisch Instituut van Nederland (ICIN), heeft 
geleid tot dit proefschrift. Per 1 januari 2014 zette zij haar opleiding cardiologie voort in 
het Sint Franciscus Gasthuis, alwaar zij tot op heden werkt op de afdeling Interne Genees-
kunde in het kader van de interne-vooropleiding (opleider Drs. A Rietveld). Zij zal haar 
opleiding voortzetten op de afdeling cardiologie in het Sint Franciscus Gasthuis, waarna 
zij weer terug zal keren naar het LUMC om daar haar cardiologie opleiding af te ronden.


